Other and unspecified coagulation defects

D3_COAGDEFNAS

blood coagulation disease: A condition in which there is a deviation from or interruption of the normal coagulation properties of the blood.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D68.8, D68.9 Hospital discharge: ICD-9 — 2869 Hospital discharge: ICD-8 — 2869 Cause of death: ICD-10 — D68.8, D68.9 Cause of death: ICD-9 — 2869 Cause of death: ICD-8 — 2869 2 out of 7 registries used, show all original rules.	2274
4. Check minimum number of events None	2274
5. Include endpoints None	2274
6. Filter based on genotype QC (FinnGen only)	2063

Control definitions (FinnGen only)

Control exclude: D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	D3_COAGDEFNAS
CONTROL_EXCLUDE	D3_COAGDEF_PURPUR_HAEMORRHAGIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D68[8-9]
HD_ICD_9	2869
HD_ICD_8	2869
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D68[8-9]
COD_ICD_9	2869
COD_ICD_8	2869
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified coagulation defects based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11374	7399	3902
Only index persons	10454	6997	3457
Unadjusted period prevalence (%)
Whole population	0.18	0.21	0.11
Only index persons	0.22	0.26	0.13
Median age at first event (years)
Whole population	41.80	37.06	50.90
Only index persons	41.92	37.10	51.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2063	1429	634
Unadjusted period prevalence (%)	0.44	0.51	0.29
Median age at first event (years)	47.51	42.97	57.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2147: Matched controls
21470

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B01AB04

ATC

dalteparin; parenteral

11.4

307.7

423

451

B01AA03

ATC

warfarin; systemic

11.3

307.7

1005

1545

B01AB05

ATC

enoxaparin; parenteral

8.3

307.7

1437

4196

D68.9

ICD-10 Finland

Coagulation defect, unspecified

2279.9

307.7

506

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

12.9

307.7

347

317

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

17.8

307.7

324

212

D68.8

ICD-10 Finland

Other specified coagulation defects

4558.5

307.7

1754

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

9.9

292.7

369

443

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

36.3

276.3

174

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

11.7

269.3

293

286

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.4

231.3

559

1314

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

18.0

226.5

187

113

K94

ICPC

Phlebitis/thrombophlebitis

16.9

183.9

156

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

569.6

162.2

159

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

15.2

157.3

141

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

11.9

132.4

137

122

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

6.0

130.5

247

454

Z2221

NOMESCO Finland

Medical doctor

3.0

128.7

901

4173

XF400

NOMESCO Finland

ECG with 12 standard connections

3.6

119.7

492

1655

K99

ICPC

Cardiovascular disease other

9.6

119.6

144

159

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

34.3

114.7

D68.0

ICD-10 Finland

Von Willebrand disease

571.7

110.9

109

R4110

NOMESCO Finland

Physiotherapy

2.8

110.6

818

3840

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

6.3

110.3

197

341

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.2

104.7

525

1981

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

94.0

1156

6811

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

9.7

89.5

106

114

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.1

89.2

274

747

I87.0

ICD-10 Finland

Postthrombotic syndrome

36.9

86.6

ZXD10

NOMESCO Finland

Scheduled procedure

2.4

86.1

972

5444

B01AB10

ATC

tinzaparin; parenteral

3.3

84.8

368

1261

Z3231

NOMESCO Finland

Registered nurse

2.5

84.8

748

3739

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

9.9

84.1

103

Z3226

NOMESCO Finland

Physiotherapist

2.8

83.6

541

2319

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

17.3

80.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

80.7

426

1634

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

8.6

78.3

102

124

ZXE00

NOMESCO Finland

One hour or less

2.3

76.8

1027

6106

K93

ICPC

Pulmonary embolism

13.2

76.2

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

74.5

887

5006

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

11.6

70.2

I26

ICD-10 Finland

Pulmonary embolism

12.0

69.9

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

32.8

69.7

R06.0

ICD-10 Finland

Dyspnoea

2.3

69.0

708

3725

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

3.0

67.4

355

1351

N02AX02

ATC

tramadol; systemic, rectal

2.2

66.1

1016

6277

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

65.7

583

2868

M79.6

ICD-10 Finland

Pain in limb

2.1

64.0

1136

7390

K78

ICPC

Atrial fibrillation/flutter

3.8

62.7

205

580

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

61.2

660

3515

B01AX05

ATC

fondaparinux; parenteral

15.1

59.8

WX892

NOMESCO Finland

Monitored bed care

3.4

58.1

231

742

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.2

56.4

247

841

R4120

NOMESCO Finland

Occupational therapy

3.3

55.1

220

708

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.8

53.9

318

1276

Z71.8

ICD-10 Finland

Other specified counselling

2.0

53.7

927

5849

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.6

52.9

188

561

B01AF02

ATC

apixaban; oral

2.8

52.5

308

1232

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

52.2

684

3892

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

51.7

266

992

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

16.9

51.4

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

50.4

720

4222

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

10.8

49.8

AA1AD

NOMESCO Finland

CT of head and brain

2.1

48.6

632

3571

R60.0

ICD-10 Finland

Localized oedema

2.6

48.6

323

1373

126

Kela drug reimbursment

Chronic coagulation defects

+∞

48.1

TPH07

NOMESCO Finland

Cathetrisation of artery

2.7

47.9

282

1127

ZXD05

NOMESCO Finland

Urgent procedure

2.0

47.4

765

4663

L17

ICPC

Foot/toe symptom/complaint

2.0

47.1

760

4631

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

46.8

273

1086

ZX120

NOMESCO Finland

Intravenous

2.8

46.6

260

1010

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.3

46.5

188

608

B01AF01

ATC

rivaroxaban; oral

2.6

45.8

296

1239

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

45.4

391

1867

H02AB07

ATC

prednisone; oral

2.4

44.8

341

1541

C03CA01

ATC

furosemide; systemic

2.1

43.2

536

2956

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

42.6

367

1749

L04AA06

ATC

mycophenolic acid; systemic

5.6

41.4

148

WX002

NOMESCO Finland

Sedation and analgesia

2.2

41.4

442

2298

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

9.8

41.3

ZXE20

NOMESCO Finland

More than three and less than five hours

2.4

40.6

318

1452

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

40.6

922

6211

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

7.4

40.3

Z2446

NOMESCO Finland

Social worker

2.9

40.0

209

782

XA800

NOMESCO Finland

Neuropsychological investigation

3.4

39.8

147

449

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

6.7

39.2

3AC01, ,

NOMESCO Finland

8.4

39.0

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

5.7

38.7

132

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.0

38.1

183

654

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.4

37.7

225

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

37.6

1011

7115

N03AX16

ATC

[U] pregabalin

2.0

37.6

521

2971

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

37.2

505

2859

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

36.9

989

6943

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.2

36.4

153

506

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.1

36.1

103

263

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

363.2

36.1

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.3

35.7

141

449

XF404

NOMESCO Finland

Ambulatory ECG

2.6

34.1

206

830

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

33.8

342

1729

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

33.7

609

3772

ZXA05

NOMESCO Finland

Left side

1.9

33.5

491

2841

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

9.9

33.0

J01MA12

ATC

levofloxacin; systemic

2.1

33.0

395

2127

H02AB06

ATC

prednisolone; systemic

1.7

32.5

1025

7447

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.8

32.2

175

667

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.7

32.0

105

296

ZXA00

NOMESCO Finland

Right side

1.9

31.8

532

3208

L04AX01

ATC

azathioprine; systemic

3.2

31.4

128

415

P01BA02

ATC

hydroxychloroquine; oral

2.5

31.4

218

938

315

Kela drug reimbursment

Clopidogrel

8.1

31.2

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

31.1

518

3117

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

31.0

645

4153

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

30.6

152

552

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

30.4

729

4884

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

30.4

280

1361

K29

ICPC

Cardiovascular sympt/complt other

3.5

30.2

107

318

C07AB07

ATC

bisoprolol; oral

1.7

29.7

894

6366

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

29.3

149

548

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

29.2

120

391

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

29.2

450

2634

N02BE01

ATC

paracetamol; systemic, rectal

2.3

28.7

1931

17147

Z01.7

ICD-10 Finland

Laboratory examination

1.9

28.6

422

2433

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

28.4

226

1032

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.4

27.9

199

865

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.7

27.6

253

A97

ICPC

No disease

1.8

27.4

478

2904

L28

ICPC

Limited function/disability (L)

1.9

27.3

376

2115

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

26.9

442

2632

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

2.1

26.4

266

1336

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.7

26.3

153

603

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.0

26.2

117

400

A08

ICPC

Swelling

2.7

26.2

143

546

A02BC02

ATC

pantoprazole; systemic

1.7

26.1

1428

11683

A02BC01

ATC

omeprazole; systemic

1.7

26.1

569

3682

A46

ICD-10 Finland

Erysipelas

2.1

26.1

295

1547

R51.80

ICD-10 Finland

Headache

1.8

26.0

428

2549

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

25.7

259

1300

K84

ICPC

Heart disease other

4.0

25.6

191

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.6

25.6

154

618

R04.0

ICD-10 Finland

Epistaxis

2.5

25.4

167

699

K92.1

ICD-10 Finland

Melaena

2.9

25.4

120

424

J01MA02

ATC

ciprofloxacin; systemic

1.6

25.3

770

5437

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

25.2

202

924

ZXD35

NOMESCO Finland

Usual procedure

3.5

24.7

262

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

24.5

305

1653

127

Kela drug reimbursment

Transplant complication

5.1

24.5

105

J01DB01

ATC

cefalexin; oral

1.9

24.4

1800

15801

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

24.4

834

6048

R50.9

ICD-10 Finland

Fever, unspecified

1.9

24.3

354

2023

XW000

NOMESCO Finland

Bone marrow biopsy

3.3

24.3

290

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.1

24.3

167

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

24.2

219

1053

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

24.1

177

779

H53.1

ICD-10 Finland

Subjective visual disturbances

2.3

24.0

185

832

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

7.5

23.8

S97

ICPC

Chronic ulcer skin

2.7

23.7

136

532

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

23.7

117

423

R42

ICD-10 Finland

Dizziness and giddiness

1.8

23.7

476

2999

TK800

NOMESCO Finland

Hemodialysis

4.5

23.7

132

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.1

23.5

158

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

19.7

23.5

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.8

23.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

23.2

258

1342

WX402

NOMESCO Finland

General anaesthesia

1.7

23.2

518

3360

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

23.0

316

1769

J01FF01

ATC

clindamycin; systemic

1.7

22.9

573

3829

XF620

NOMESCO Finland

Examination of circulation with color method

8.6

22.8

ZXA10

NOMESCO Finland

Bilateral

1.8

22.7

367

2166

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

4.2

22.4

142

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

32.6

22.4

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

22.0

242

1253

K22

ICPC

Risk factor cardiovascular disease

2.6

21.9

131

524

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.0

21.9

158

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

21.7

149

636

D68

ICD-10 Finland

Other coagulation defects

116.2

21.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

21.4

443

2807

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

21.2

705

5036

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.8

21.2

109

403

B99

ICPC

Blood/lymph/spleen disease other

9.1

21.2

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.9

21.1

J01MA14

ATC

moxifloxacin; systemic

2.2

21.0

195

946

B83

ICPC

Purpura/coagulation defect

+∞

20.9

R03DC03

ATC

montelukast; oral

1.8

20.8

395

2440

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.9

20.6

348

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

20.5

602

4169

S16

ICPC

Bruise/contusion

3.2

20.5

253

C10AA05

ATC

atorvastatin; oral

1.6

20.4

719

5198

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

20.4

279

1558

A28

ICPC

Limited function/disability NOS

1.9

20.3

305

1754

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

20.2

505

3357

N96

ICD-10 Finland

Habitual aborter

5.6

20.1

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

17.5

20.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

20.0

365

2226

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.8

19.7

161

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.0

19.6

139

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

19.6

140

608

L04AD02

ATC

tacrolimus; systemic

5.2

19.6

L14

ICPC

Leg/thigh symptom/complaint

2.1

19.5

193

959

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

19.5

1580

13653

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

19.3

149

670

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

31.6

19.3

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

19.1

147

660

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

19.1

171

818

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.4

19.0

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

19.0

172

826

Z2445

NOMESCO Finland

Psychologist

2.6

18.8

115

465

28698

ICD-8 Finland

Coagulation defects, Other

+∞

18.8

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

18.7

306

1804

R53

ICD-10 Finland

Malaise and fatigue

1.6

18.6

573

3997

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.1

18.5

123

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.8

18.5

363

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.5

18.4

183

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.6

18.4

111

446

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

18.3

126

539

B02AA02

ATC

tranexamic acid; systemic

1.7

18.2

354

2194

R4130

NOMESCO Finland

Speech therapy

3.2

18.1

230

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

18.1

164

787

Z35.1

ICD-10 Finland

Supervision of pregnancy with history of abortive outcome

6.2

18.1

R4190

NOMESCO Finland

Nutritional therapy

2.6

18.1

111

449

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.5

18.0

176

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.2

18.0

152

709

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

18.0

179

891

L04AD01

ATC

ciclosporin; systemic

3.8

18.0

148

J01FA06

ATC

roxithromycin; oral

1.5

18.0

805

6092

PH2AE, ,

SPAT

3.1

17.9

242

A11CC03

ATC

alfacalcidol; systemic

3.6

17.9

172

R03BA02

ATC

budesonide; inhalant

1.7

17.9

396

2543

D66

ICD-10 Finland

Hereditary factor VIII deficiency

+∞

17.7

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

17.6

610

4363

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

17.6

1659

18155

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

95.9

17.6

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

17.5

143

658

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

17.4

154

732

Z71.9

ICD-10 Finland

Counselling, unspecified

2.0

17.4

204

1078

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

17.2

126

553

K27

ICPC

Fear cardiovascular disease other

5.8

17.1

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

17.1

302

1819

R06AE07

ATC

cetirizine; oral

1.5

17.1

962

7605

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

17.1

116

493

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

17.0

107

438

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

17.0

424

2803

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

17.0

482

3288

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

6.0

17.0

A02BC05

ATC

esomeprazole; systemic

1.5

16.8

806

6163

JN4BD

NOMESCO Finland

Extensive body CT

2.0

16.8

185

956

R5110, ,

SPAT

2.1

16.8

173

873

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

16.7

172

868

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.4

16.7

116

498

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

16.6

1220

10141

D69.1

ICD-10 Finland

Qualitative platelet defects

171.3

16.5

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

16.5

181

935

XF402

NOMESCO Finland

ECG with work load test

2.0

16.4

189

992

UJF32

NOMESCO Finland

Coloscopy

1.6

16.4

476

3263

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

16.2

462

3150

R02

ICPC

Shortness of breath/dyspnoea

1.8

16.2

278

1660

M05BA04

ATC

alendronic acid; oral

2.2

16.0

145

696

O28.0

ICD-10 Finland

Abnormal haematological finding on antenatal screening of mother

24.7

16.0

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

13.7

16.0

WW200

NOMESCO Finland

Immunization

3.1

15.9

227

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

15.9

152

745

A01

ICPC

Pain general/multiple sites

1.9

15.8

224

1260

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

15.8

122

548

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

15.8

363

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.1

15.8

223

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

15.8

195

1050

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

5.9

15.7

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

15.7

361

2334

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

15.7

419

2812

D68.4

ICD-10 Finland

Acquired coagulation factor deficiency

+∞

15.6

J01AA02

ATC

doxycycline; systemic

1.5

15.6

1581

13912

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

15.5

212

1180

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

15.5

1121

9236

R52.9

ICD-10 Finland

Pain, unspecified

1.8

15.5

231

1322

J20

ICD-10 Finland

Acute bronchitis

1.8

15.4

235

1355

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.9

15.3

243

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.5

15.3

151

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

15.1

182

970

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

14.9

139

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

14.8

241

1415

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

14.8

193

1057

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

14.8

390

2607

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

14.6

228

1321

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

14.6

374

2480

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.7

14.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

14.5

180

971

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

14.4

142

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

14.4

100

429

E0000UV, ,

ATC

1.4

14.4

872

6919

B01AE07

ATC

dabigatran etexilate; oral

2.9

14.3

247

A07AA02

ATC

nystatin; oral

2.2

14.3

116

533

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

14.3

126

599

R03AC02

ATC

salbutamol; inhalant

1.4

14.3

1176

9859

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

14.3

103

450

WW500

NOMESCO Finland

Blood transfusion

2.6

14.3

322

D69.0

ICD-10 Finland

Allergic purpura

22.4

14.2

S29

ICPC

Skin symptom/complaint other

1.6

14.2

413

2822

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

14.2

656

4945

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.7

14.0

301

EB1AA, ,

SPAT

2.0

14.0

158

823

PA6AD

NOMESCO Finland

CT of neck arteries

2.5

14.0

361

ZXD20

NOMESCO Finland

Day surgery

1.7

14.0

261

1594

N03AF02

ATC

oxcarbazepine; oral

2.6

13.9

314

O36.4

ICD-10 Finland

Maternal care for intrauterine death

5.6

13.8

K90

ICPC

Stroke/cerebrovascular accident

3.0

13.8

208

J01MA06

ATC

norfloxacin; oral

1.7

13.8

255

1552

C01CA24

ATC

epinephrine; parenteral

1.9

13.7

166

886

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

13.7

282

Z31.5

ICD-10 Finland

Genetic counselling

2.0

13.6

146

747

D01

ICPC

Abdominal pain/cramps general

1.7

13.6

290

1835

J45

ICD-10 Finland

Asthma

1.8

13.6

233

1389

X58

ICD-10 Finland

Exposure to other specified factors

1.6

13.6

323

2102

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

13.4

185

1031

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.6

13.4

120

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.6

13.4

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

13.4

297

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.4

13.3

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.8

13.3

229

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.6

13.3

292

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

13.2

792

6246

J01FA10

ATC

azithromycin; systemic

1.4

13.1

1242

10596

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.4

13.1

PHD99

NOMESCO Finland

Resection of other vein

2.1

13.1

122

593

M25.5

ICD-10 Finland

Pain in joint

1.4

13.1

716

5553

R55

ICD-10 Finland

Syncope and collapse

1.8

13.0

198

1138

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.2

13.0

R31

ICD-10 Finland

Unspecified haematuria

1.9

12.9

168

919

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

12.9

489

3530

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

2.3

12.8

433

H53.4

ICD-10 Finland

Visual field defects

3.1

12.8

169

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

12.8

475

3415

N02AA05

ATC

oxycodone; systemic

1.6

12.8

290

1864

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.8

12.7

101

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

12.7

224

G44.2

ICD-10 Finland

Tension-type headache

1.6

12.7

314

2061

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.3

12.7

R07.3

ICD-10 Finland

Other chest pain

1.8

12.6

217

1293

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.5

12.6

N30.0

ICD-10 Finland

Acute cystitis

1.6

12.6

368

2512

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.7

12.5

254

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

12.5

391

2708

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

12.5

266

-60

ICPC

Result test/procedure

2.1

12.4

115

557

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

130.8

12.4

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

12.4

442

3147

H02AB04

ATC

methylprednisolone; systemic

1.6

12.4

276

1763

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

5.7

12.4

R03BB04

ATC

tiotropium bromide; inhalant

1.9

12.4

172

961

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

12.4

147

780

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

12.4

113

545

C10AA01

ATC

simvastatin; oral

1.5

12.4

585

4407

L04AA01

ATC

[U] ciclosporin

3.9

12.4

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

12.4

239

1472

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

12.4

297

1935

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.5

12.2

118

L12

ICPC

Hand/finger symptom/complaint

1.5

12.2

372

2561

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.0

12.2

133

685

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

12.2

232

1422

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.0

12.2

I63

ICD-10 Finland

Cerebral infarction

6.0

12.1

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.7

12.1

100

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

12.1

193

1126

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.4

12.1

129

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

12.0

176

1001

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

12.0

117

579

N18.8

ICD-10 Finland

Other chronic renal failure

3.5

12.0

120

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

11.9

102

479

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

5.0

11.9

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

11.9

191

1115

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

11.9

166

929

WX872

NOMESCO Finland

Intensive care

2.3

11.9

402

M54.5

ICD-10 Finland

Low back pain

1.4

11.9

779

6212

H02AB09

ATC

hydrocortisone; systemic

2.8

11.9

221

T14.0

ICD-10 Finland

Superficial injury of unspecified body region

3.8

11.8

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

11.8

199

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

11.8

456

3297

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

11.8

165

924

R2110

NOMESCO Finland

Giving the first information

1.9

11.7

153

838

D07AB08

ATC

desonide; topical

1.7

11.7

222

1360

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.3

11.7

137

A99

ICPC

Disease/condition unspecnature/site

1.7

11.6

214

1300

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.9

11.6

160

892

PA2AD

NOMESCO Finland

CT angiography of brain

4.1

11.6

RD210, ,

NOMESCO Finland

3.1

11.6

153

A29

ICPC

General symptom/complaint other

1.6

11.6

259

1657

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.4

11.5

118

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

11.5

414

M04AA01

ATC

allopurinol; systemic

1.8

11.5

183

1066

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

11.5

219

P01AB01

ATC

metronidazole; oral, rectal

1.4

11.5

818

6605

NHQ40

NOMESCO Finland

Amputation of toe

4.1

11.4

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

11.4

209

A11

ICPC

Chest pain NOS

1.8

11.4

163

920

J01DA06

ATC

[U] cefuroxime

1.6

11.3

282

1851

R11

ICD-10 Finland

Nausea and vomiting

1.8

11.3

188

1109

TAB00

NOMESCO Finland

Lumbar puncture

2.1

11.3

103

497

C03DA01

ATC

spironolactone; oral

1.7

11.3

201

1210

I81

ICD-10 Finland

Portal vein thrombosis

9.7

11.2

D06

ICPC

Abdominal pain localized other

1.7

11.2

196

1173

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

11.2

259

1669

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.8

11.2

G47.3

ICD-10 Finland

Sleep apnoea

1.5

11.2

424

3052

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

11.1

225

1402

R06AX27

ATC

desloratadine; oral

1.4

11.1

653

5097

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.7

11.1

212

TK810

NOMESCO Finland

Hemofiltration

8.1

11.1

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

11.0

201

1217

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.4

11.0

326

Z01.2

ICD-10 Finland

Dental examination

1.4

11.0

1000

8376

RS220, ,

NOMESCO Finland

3.4

11.0

112

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

4.8

11.0

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.3

11.0

384

205

Kela drug reimbursment

Chronic hypertension

1.5

10.9

352

2449

WX110, ,

SPAT

1.9

10.9

133

713

WX722

NOMESCO Finland

PEEP

2.3

10.8

386

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

10.8

110

553

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

2.0

10.8

114

581

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

10.7

325

2230

WX890

NOMESCO Finland

Intesive care monitoring

4.9

10.7

Z92.1

ICD-10 Finland

Personal history of long-term (current) use of anticoagulants

28.2

10.7

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

2.4

10.7

325

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

10.6

840

6872

K60

ICPC

Cardiovascular, Result test/procedure

5.3

10.6

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.7

10.6

206

L02

ICPC

Back symptom/complaint

1.6

10.6

238

1524

C08CA05

ATC

nifedipine; systemic

2.1

10.6

103

510

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.1

10.6

483

R04.2

ICD-10 Finland

Haemoptysis

2.6

10.5

247

J01CA04

ATC

amoxicillin; systemic

1.5

10.5

1738

15975

K91

ICPC

Cerebrovascular disease

4.0

10.5

J05AB11

ATC

valaciclovir; oral

1.6

10.5

295

1992

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

10.5

575

4429

2869X

ICD-9 Finland

Coagulation defects, Other and unspecified coagulation defects

+∞

10.4

J02AC01

ATC

fluconazole; systemic

1.4

10.4

846

6944

A60

ICPC

General and Unspecified, Result test/procedure

2.2

10.4

432

S21

ICPC

Skin texture symptom/complaint

1.6

10.4

295

1995

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.7

10.4

R05

ICPC

Cough

1.4

10.4

521

3949

N05CF01

ATC

zopiclone; oral

1.4

10.4

561

4308

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

10.3

273

1817

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

10.3

203

E66.8

ICD-10 Finland

Other obesity

1.9

10.3

136

748

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.2

10.3

427

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.5

10.3

262

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

2.5

10.3

250

N03AX09

ATC

lamotrigine; oral

1.9

10.3

122

648

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

18.9

10.3

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

10.3

199

1226

A02BA02

ATC

ranitidine; systemic

1.5

10.2

319

2202

L29

ICPC

Musculoskeletal sympt/complt other

1.7

10.2

178

1065

F29

ICPC

Eye symptom/complaint other

1.6

10.2

219

1386

A07DA03

ATC

loperamide; oral

2.6

10.1

228

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.8

10.1

177

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

11.3

10.0

N06AB04

ATC

citalopram; systemic

1.5

10.0

395

2859

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

10.0

206

D45

ICD-10 Finland

Polycythaemia vera

4.5

10.0

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.2

10.0

119

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.6

10.0

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

10.0

148

844

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

10.0

179

1079

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

14.6

10.0

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

10.0

156

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.1

10.0

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

10.0

109

563

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

10.0

335

SPAT1229

SPAT

Assessment of need for aid

1.9

9.9

118

627

N20.0

ICD-10 Finland

Calculus of kidney

2.9

9.9

162

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

9.9

265

1767

M35.1

ICD-10 Finland

Other overlap syndromes

7.7

9.9

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

9.9

141

795

L01BA01

ATC

methotrexate; systemic

2.3

9.9

317

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

9.9

116

614

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.6

9.9

248

1630

WW400

NOMESCO Finland

Plasmaferesis

16.8

9.9

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

12.2

9.8

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.7

9.8

191

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

9.8

169

1009

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.7

9.8

186

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

9.6

9.8

Z35

ICD-10 Finland

Supervision of high-risk pregnancy

3.5

9.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.4

9.7

101

A91

ICPC

Abnormal result investigation NOS

2.0

9.7

111

582

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

9.7

111

582

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.5

9.7

382

2763

W84

ICPC

Pregnancy high risk

2.0

9.7

101

513

K92

ICPC

Atherosclerosis/periph vascular dis

4.2

9.6

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.2

9.6

399

XX9XW, ,

NOMESCO Finland

4.3

9.6

WX213

NOMESCO Finland

Lower leg blockade

4.3

9.6

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

9.6

168

1007

I82

ICD-10 Finland

Other venous embolism and thrombosis

11.4

9.6

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

9.6

215

1376

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

9.6

120

650

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.7

9.5

194

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.8

9.5

177

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

15.1

9.5

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

9.5

405

2974

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

9.5

150

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

9.5

138

784

ZZA00

NOMESCO Finland

Split skin graft

2.7

9.5

195

N03AG01

ATC

valproic acid; systemic, rectal

1.9

9.4

122

667

J01DA01

ATC

[U] cefalexin

1.3

9.4

1219

10663

A23

ICPC

Risk factor NOS

1.6

9.4

221

1429

J01DC02

ATC

cefuroxime; systemic

1.9

9.4

117

632

N03AX12

ATC

[U] gabapentin; oral

1.5

9.4

292

2013

S18

ICPC

Laceration/cut

1.3

9.4

867

7223

2BD06, ,

NOMESCO Finland

+∞

9.4

I82.0

ICD-10 Finland

Budd-Chiari syndrome

+∞

9.4

D69.4

ICD-10 Finland

Other primary thrombocytopenia

+∞

9.4

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

9.3

194

1217

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

9.3

214

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.9

9.3

XPX08

NOMESCO Finland

Intraoperative flow measurement

4.5

9.3

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

9.3

432

3224

R52.0

ICD-10 Finland

Acute pain

2.1

9.2

392

M05BX04

ATC

denosumab; parenteral

2.0

9.2

495

A12AA04

ATC

calcium carbonate; oral

3.4

9.2

N03AX14

ATC

levetiracetam; systemic

2.4

9.2

252

M03BX02

ATC

tizanidine; oral

1.3

9.2

1266

11157

Z94.0

ICD-10 Finland

Kidney transplant status

3.9

9.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

9.1

177

1090

B01AC04

ATC

clopidogrel; oral

1.6

9.1

229

1504

N05BA01

ATC

diazepam; systemic, rectal

1.6

9.1

232

1531

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

9.0

222

1451

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

9.0

317

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

9.0

207

1331

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

9.0

571

4489

I50.0

ICD-10 Finland

Congestive heart failure

2.0

9.0

479

R03AK08

ATC

formoterol and beclometasone; inhalant

2.0

8.9

494

ZX108

NOMESCO Finland

Inhalation

4.3

8.9

H05AA02

ATC

teriparatide; parenteral

8.0

8.8

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.9

8.8

XMA22

NOMESCO Finland

General examination of pregnant woman

1.7

8.8

146

861

K63.5

ICD-10 Finland

Polyp of colon

2.8

8.8

156

C08CA01

ATC

amlodipine; oral

1.4

8.8

583

4609

R81

ICPC

Pneumonia

2.2

8.8

353

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.7

8.8

179

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.4

8.8

251

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.3

8.8

276

R83

ICPC

Respiratory infection other

1.4

8.8

584

4621

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

9.5

8.8

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

8.8

140

N18.0

ICD-10 Finland

End-stage renal disease

4.1

8.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

8.7

295

2069

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

8.7

178

1112

L04AX03

ATC

methotrexate; systemic

1.6

8.7

187

1183

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

8.7

186

M32

ICD-10 Finland

Systemic lupus erythematosus

14.1

8.7

D69.5

ICD-10 Finland

Secondary thrombocytopenia

50.2

8.7

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.8

8.7

152

XQ800

NOMESCO Finland

Prick test

1.7

8.7

169

1043

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

8.7

146

866

R01AD09

ATC

mometasone; nasal

1.3

8.6

955

8133

R06.4

ICD-10 Finland

Hyperventilation

2.9

8.6

136

XX9XE

NOMESCO Finland

Other ultrasound examination

4.0

8.6

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

4.6

8.6

L88

ICPC

Rheumatoid/seropositive arthritis

2.1

8.6

397

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

8.6

134

778

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

8.5

391

RS221, ,

NOMESCO Finland

3.0

8.5

121

I74.8

ICD-10 Finland

Embolism and thrombosis of other arteries

20.1

8.5

M02AA07

ATC

piroxicam; topical

1.4

8.4

593

4728

JN4AD

NOMESCO Finland

Body CT examination

1.6

8.4

187

1193

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

8.4

103

554

L01XX05

ATC

hydroxycarbamide; oral

3.6

8.4

R52.2

ICD-10 Finland

Other chronic pain

2.0

8.4

421

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

8.4

212

1395

WX320

NOMESCO Finland

Spinalanesthesy

1.4

8.4

440

3347

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.9

8.4

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

8.4

408

M10.9

ICD-10 Finland

Gout, unspecified

1.9

8.3

100

534

D10

ICPC

Vomiting

1.7

8.3

145

868

W19

ICD-10 Finland

Unspecified fall

1.6

8.3

179

1133

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.1

8.3

355

280

Kela drug reimbursment

Clopidogrel

3.6

8.3

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

8.3

360

2649

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

8.3

465

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

8.3

171

1072

K07

ICPC

Swollen ankles/oedema

2.1

8.2

397

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

8.2

127

735

S06.0

ICD-10 Finland

Concussion

1.6

8.2

209

1378

M79.1

ICD-10 Finland

Myalgia

1.5

8.2

326

2359

J01FA09

ATC

clarithromycin; systemic

1.3

8.2

606

4865

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

3.7

8.2

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.2

635

5135

R03AC03

ATC

terbutaline; inhalant

1.5

8.1

262

1818

N05BA04

ATC

oxazepam; oral

1.4

8.1

495

3856

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

8.1

254

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

4.8

8.1

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

8.1

155

952

M01AH02

ATC

rofecoxib; oral

1.6

8.1

193

1253

I82.1

ICD-10 Finland

Thrombophlebitis migrans

33.5

8.1

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

8.1

306

C08CA02

ATC

felodipine; oral

1.7

8.1

133

784

318

Kela drug reimbursment

Teriparatide

6.8

8.1

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

1.8

8.1

110

613

A03

ICPC

Fever

1.4

8.0

377

2811

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

8.0

249

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

10.1

8.0

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

8.0

233

1582

L03

ICPC

Low back symptom/complaint

1.3

8.0

591

4740

G72.9

ICD-10 Finland

Myopathy, unspecified

4.1

8.0

R03BB01

ATC

ipratropium bromide; inhalant

2.4

8.0

237

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.1

8.0

104

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

8.0

301

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

8.0

361

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

1.4

7.9

354

2617

R13

ICD-10 Finland

Dysphagia

1.7

7.9

130

766

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.4

7.9

L05

ICPC

Flank/axilla symptom/complaint

1.7

7.9

129

759

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.6

7.9

R03BA05

ATC

fluticasone; inhalant

1.4

7.9

349

2575

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.8

7.9

132

ZXE90

NOMESCO Finland

More than 22 hours

6.1

7.8

GD1LA

NOMESCO Finland

3.1

7.8

100

N02AC04

ATC

dextropropoxyphene; oral

2.4

7.8

227

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.1

7.8

WVA20

NOMESCO Finland

Medicine administration

2.3

7.8

265

WX212

NOMESCO Finland

Femoral plexus blockade

2.6

7.8

161

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

10.8

7.8

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

9.4

7.8

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

7.8

215

1444

C09AA05

ATC

ramipril; oral

1.4

7.7

355

2636

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.8

7.7

106

592

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

6.4

7.7

H53.2

ICD-10 Finland

Diplopia

2.2

7.7

299

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

7.7

220

1489

Z49.2

ICD-10 Finland

Other dialysis

4.5

7.6

RS230, ,

NOMESCO Finland

4.5

7.6

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

7.6

207

1384

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.1

7.6

340

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.7

7.6

140

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.9

7.6

118

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

6.7

7.6

SPAT1336

SPAT

Request for examination

2.1

7.6

341

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.1

7.6

348

N05CF02

ATC

zolpidem; oral

1.4

7.6

326

2393

R33

ICD-10 Finland

Retention of urine

1.8

7.5

105

589

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

7.5

424

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.6

7.5

158

WYA30, ,

SPAT

4.1

7.5

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

6.2

7.5

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

7.5

247

1720

I74.2

ICD-10 Finland

Embolism and thrombosis of arteries of upper extremities

10.1

7.5

S20.2

ICD-10 Finland

Contusion of thorax

1.9

7.5

546

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

7.5

234

1613

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

7.5

147

ZX114

NOMESCO Finland

Intramuscular

2.9

7.5

119

R07.1

ICD-10 Finland

Chest pain on breathing

2.8

7.5

136

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

7.4

287

2063

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

7.4

297

N01

ICPC

Headache

1.5

7.4

264

1869

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.5

7.4

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.2

7.4

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.0

7.4

109

U07

ICPC

Urine symptom/complaint other

1.6

7.4

150

936

J94.8

ICD-10 Finland

Other specified pleural conditions

3.4

7.4

R1260

NOMESCO Finland

Evaluation of communicative skills

2.9

7.4

120

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.2

7.4

278

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

7.4

104

586

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.5

7.4

242

1686

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.8

7.4

N06AX11

ATC

mirtazapine; oral

1.3

7.4

651

5347

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

7.4

285

L01

ICPC

Neck symptom/complaint

1.4

7.4

337

2500

I50.1

ICD-10 Finland

Left ventricular failure

2.1

7.3

305

D07AC01

ATC

betamethasone; topical

1.3

7.3

672

5546

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

7.3

110

632

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.0

7.3

394

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

7.3

493

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

7.3

O991, D688,

ICD-10 Finland

+∞

7.3

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.3

530

4233

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

7.3

280

2012

A12BA01

ATC

potassium chloride; oral

2.3

7.3

241

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

7.3

126

754

C09CA06

ATC

candesartan; oral

1.4

7.3

432

3346

WZC30

NOMESCO Finland

Teaching

1.4

7.3

291

2107

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

7.2

320

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.3

7.2

235

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

7.2

354

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

15.8

7.2

R76.8

ICD-10 Finland

Other specified abnormal immunological findings in serum

15.8

7.2

N06AA09

ATC

amitriptyline; systemic

1.6

7.2

155

981

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.6

7.2

171

1109

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

7.2

124

741

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.6

7.2

166

1070

S11

ICPC

Skin infection post-traumatic

3.1

7.2

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.0

7.2

390

B01AF03

ATC

edoxaban; oral

2.6

7.1

151

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

7.1

476

A06AD11

ATC

lactulose; oral

1.5

7.1

213

1456

A04

ICPC

Weakness/tiredness general

1.4

7.1

308

2263

ZXE80

NOMESCO Finland

More than 18 and less than 21 hours

12.1

7.1

WX882

NOMESCO Finland

High dependency care

2.3

7.0

238

L15

ICPC

Knee symptom/complaint

1.3

7.0

464

3650

R21

ICPC

Throat symptom/complaint

1.3

7.0

475

3750

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

7.0

252

1786

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.9

7.0

107

6BA02, ,

NOMESCO Finland

7.0

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

7.0

104

596

SBB10

NOMESCO Finland

Dental impressions

1.6

7.0

143

895

SPAT1260

SPAT

Consultation of another employee

1.4

7.0

300

2200

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

7.0

134

825

R4120, ,

SPAT

3.0

6.9

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.0

6.9

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.1

6.9

326

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.7

6.9

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.1

6.9

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

6.9

431

XCK00

NOMESCO Finland

Perimetry

1.8

6.9

503

K02.9

ICD-10 Finland

Dental caries, unspecified

2.5

6.9

160

S76

ICPC

Skin infection other

1.8

6.9

555

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.5

6.9

203

1384

ZY010

NOMESCO Finland

Hospital outpatient

1.7

6.8

117

698

D11

ICPC

Diarrhoea

1.5

6.8

255

1821

V03AE01

ATC

polystyrene sulfonate; oral

3.4

6.8

R05

ICD-10 Finland

Cough

1.4

6.8

411

3187

I70.8

ICD-10 Finland

Atherosclerosis of other arteries

8.3

6.8

J01MA01

ATC

ofloxacin; systemic

1.7

6.8

129

791

I27.0

ICD-10 Finland

Primary pulmonary hypertension

11.0

6.8

A05AA02

ATC

ursodeoxycholic acid; oral

2.5

6.8

173

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

6.8

161

A10AB05

ATC

insulin aspart; parenteral

1.7

6.8

132

816

WX610

NOMESCO Finland

Patient controlled analgesia

3.6

6.7

C10AA07

ATC

rosuvastatin; oral

1.3

6.7

546

4421

D69.8

ICD-10 Finland

Other specified haemorrhagic conditions

16.7

6.7

2BD01, ,

NOMESCO Finland

16.7

6.7

PD4ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower extremity arteries

16.7

6.7

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.7

6.7

117

701

L04AA13

ATC

[U] leflunomide

2.4

6.7

192

UJH02

NOMESCO Finland

Anoscopy

2.0

6.7

371

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.6

6.7

138

R03BA01

ATC

beclometasone; inhalant

1.5

6.7

243

1725

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

6.7

421

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

6.7

206

1416

C08DB01

ATC

diltiazem; oral

2.1

6.7

310

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.7

800

6816

45001

ICD-8 Finland

Pulmonary embolism and infarction, Embolia

22.6

6.7

K76.9

ICD-10 Finland

Liver disease, unspecified

3.0

6.7

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

6.7

297

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

3.7

6.6

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

6.6

444

-49

ICPC

Other preventive procedure

4.0

6.6

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

4.0

6.6

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.7

6.6

126

774

K08.3

ICD-10 Finland

Retained dental root

1.7

6.6

128

790

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

6.6

367

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

12.3

6.6

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

6.6

265

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

6.6

240

1707

N80.0

ICD-10 Finland

Endometriosis of uterus

2.2

6.6

226

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

6.6

533

N17

ICPC

Vertigo/dizziness

1.5

6.5

224

1573

I50

ICD-10 Finland

Heart failure

2.4

6.5

170

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

10.0

6.5

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

10.0

6.5

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.5

498

4000

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

6.5

111

663

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.7

6.5

R47.0

ICD-10 Finland

Dysphasia and aphasia

3.7

6.5

J01FA15

ATC

telithromycin; oral

1.5

6.5

181

1219

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

1.6

6.5

154

1000

L84

ICD-10 Finland

Corns and callosities

2.0

6.5

314

B28

ICPC

Limited function/disability (B)

6.2

6.5

R01AD05

ATC

budesonide; nasal

1.6

6.4

145

929

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.2

6.4

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

3.9

6.4

R03AC12

ATC

salmeterol; inhalant

1.9

6.4

377

O02.0

ICD-10 Finland

Blighted ovum and nonhydatidiform mole

2.0

6.4

356

I87.9

ICD-10 Finland

Disorder of vein, unspecified

7.4

6.4

A02BC03

ATC

lansoprazole; oral

1.3

6.4

469

3741

J05AB01

ATC

aciclovir; systemic

1.3

6.4

414

3243

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

6.4

102

597

I87.8

ICD-10 Finland

Other specified disorders of veins

14.3

6.4

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.0

6.4

364

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.4

424

3336

K83

ICPC

Heart valve disease NOS

3.7

6.4

H03AA01

ATC

levothyroxine sodium; systemic

1.3

6.3

426

3356

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

2.3

6.3

204

X57

ICD-10 Finland

Unspecified privation

2.3

6.3

204

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

6.3

209

1458

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

3.6

6.3

A10AC01

ATC

insulin (human); parenteral

1.6

6.3

129

808

K92.0

ICD-10 Finland

Haematemesis

2.4

6.3

167

-64

ICPC

Encounter/prob initiated by provider

2.7

6.3

114

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

6.3

506

4090

PHQ73

NOMESCO Finland

Insertion of endovascular graft into iliac vein

+∞

6.3

B02BD02

ATC

coagulation factor VIII; parenteral

+∞

6.3

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

+∞

6.3

2873A

ICD-9 Finland

Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]

+∞

6.3

D68.1

ICD-10 Finland

Hereditary factor XI deficiency

+∞

6.3

S70.0

ICD-10 Finland

Contusion of hip

2.0

6.2

339

K80

ICPC

Cardiac arrhythmia NOS

1.6

6.2

148

961

TGC00

NOMESCO Finland

Bronchial lavation

2.3

6.2

193

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.4

6.2

162

M05BA07

ATC

risedronic acid; oral

2.3

6.2

187

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

4.0

6.2

N06AX12

ATC

bupropion; oral

1.5

6.2

165

1101

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

6.2

156

1028

A01AB09

ATC

miconazole; local oral

1.6

6.2

136

868

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

6.1

145

940

R5599

NOMESCO Finland

Other rehabilitation service

2.1

6.1

266

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.6

6.1

133

A92

ICPC

Allergy/allergic reaction NOS

1.9

6.1

398

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.9

6.1

398

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.2

6.1

207

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.0

6.1

300

I72.8

ICD-10 Finland

Aneurysm and dissection of other specified arteries

7.7

6.1

S22.3

ICD-10 Finland

Fracture of rib

1.6

6.1

123

767

H26.9

ICD-10 Finland

Cataract, unspecified

2.9

6.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

6.1

188

1293

RK110, ,

NOMESCO Finland

4.1

6.1

UJD10, ,

SPAT

2.2

6.1

227

RS222, ,

NOMESCO Finland

3.0

6.1

MBA00

NOMESCO Finland

Vacuum aspiration from uterus after delivery or abortion

2.2

6.1

234

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.6

6.0

128

N06AX21

ATC

duloxetine; oral

1.4

6.0

233

1674

O02.1

ICD-10 Finland

Missed abortion

1.6

6.0

126

793

R96

ICPC

Asthma

1.5

6.0

175

1188

N18

ICPC

Paralysis/weakness

2.6

6.0

134

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.6

6.0

I63.8

ICD-10 Finland

Other cerebral infarction

3.6

6.0

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.5

6.0

152

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

6.0

169

1139

O22.0

ICD-10 Finland

Varicose veins of lower extremity in pregnancy

6.7

6.0

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.7

6.0

111

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

429

321

16.45

307.65

2.0

1.2

10.15

3.50

u/ml

4.96

252

130

(3036489) Thrombin time

707

731

13.93

307.65

4.5

2.2

21.06

20.53

0.94

611

637

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

388

315

14.81

307.65

1.2

1.1

112.79

116.82

1.00

359

289

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

671

624

15.19

307.65

4.7

2.4

98.12

93.51

4.23

642

603

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

409

329

15.12

307.65

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

669

562

16.84

307.65

5.8

2.5

165.02

179.50

2.73

639

537

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

565

558

13.38

307.65

5.6

2.7

3.43

3.62

g/l

1.69

544

531

(4268621) Lupus anticoagulant assay

348

219

18.77

307.65

3.6

2.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

310

234

15.31

307.65

1.2

1.1

89.68

96.49

2.44

291

221

(4195642) Thrombophilia screening test

376

315

14.26

307.65

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

441

325

16.82

307.65

2.0

1.2

11.70

3.00

u/ml

5.59

223

105

(3018677) aPTT in Platelet poor plasma by Coagulation assay

886

2617

5.06

284.84

6.1

2.1

32.95

29.36

22.61

867

2533

(3033658) Prothrombin time (PT) actual/Normal

1222

4649

4.78

283.39

8.1

3.9

84.47

92.76

14.99

1190

4543

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1178

4475

4.62

270.73

4.2

1.7

1.25

1.00

mg/l

1.80

938

3398

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

343

479

8.33

239.08

6.4

3.1

0.35

0.36

iu/ml

0.12

196

246

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

170

117

15.69

192.17

1.5

1.1

—

(3032080) INR in Blood by Coagulation assay

1446

7649

3.73

181.39

47.9

12.0

1.67

1.18

inr

108.10

1264

6333

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

67.05

164.13

1.6

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

744

2922

3.37

144.28

5.1

3.5

0.81

0.82

mmol/l

1.75

715

2770

(3034426) Prothrombin time (PT)

110

19.60

140.27

1.6

1.1

31.69

27.12

4.46

110

(42870588) Differential panel, method unspecified - Blood

1190

6364

2.95

130.76

9.4

6.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

540

1845

3.57

129.08

5.0

4.2

231.54

243.21

u/l

0.92

525

1764

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

659

2576

3.25

126.45

4.4

2.5

23.06

23.13

0.05

636

2407

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

286

632

5.07

123.04

3.8

1.9

0.21

0.23

g/l

2.07

276

600

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

290

656

4.95

121.29

3.7

1.8

1.15

1.19

g/l

1.28

281

624

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

17.85

120.99

1.4

1.1

86.03

91.79

0.40

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

17.54

119.98

1.3

1.1

89.82

90.91

0.09

(3004789) Transferrin [Mass/volume] in Serum or Plasma

688

2837

3.10

119.50

4.3

2.4

2.34

2.38

g/l

0.94

658

2647

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

135

140

10.22

117.37

1.6

1.1

1.15

1.05

ratio

4.23

122

119

(3022096) Basophils/Leukocytes in Blood

1470

9136

2.93

116.28

10.4

6.5

0.68

0.24

1414

8588

(3022948) Iron [Moles/volume] in Serum or Plasma

717

3066

3.01

116.27

4.3

2.5

13.39

13.64

umol/l

0.45

697

2865

(3006504) Eosinophils/Leukocytes in Blood

1469

9128

2.93

116.22

10.3

6.4

2.81

2.83

0.15

1415

8589

(3019069) Monocytes/Leukocytes in Blood

1465

9148

2.89

113.72

10.4

6.5

8.68

8.56

0.91

1411

8622

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

24.82

111.47

1.3

1.2

75.38

64.75

—

(3002030) Lymphocytes/Leukocytes in Blood

1480

9430

2.83

107.90

10.4

6.3

27.89

28.51

1.43

1428

8979

(3018010) Neutrophils/Leukocytes in Blood

1461

9264

2.81

107.23

10.2

6.2

57.48

56.94

1.03

1421

8887

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

23.84

105.63

1.4

1.1

90.15

85.63

—

(3006315) Basophils [#/volume] in Blood

1529

9993

2.84

104.48

10.1

6.3

0.04

e9/l

1.00

1301

8708

(3001604) Monocytes [#/volume] in Blood

1524

9977

2.82

103.16

10.1

6.3

0.56

e9/l

0.11

1294

8693

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

113

111

10.69

101.96

1.6

1.1

42.03

8.27

u/ml

1.25

(3024561) Albumin [Mass/volume] in Serum or Plasma

1292

7908

2.59

98.34

7.3

4.9

36.15

36.27

g/l

0.31

1237

7451

(3019198) Lymphocytes [#/volume] in Blood

1534

10224

2.75

97.48

10.2

6.3

1.87

1.95

e9/l

1.52

1331

9144

(3013115) Eosinophils [#/volume] in Blood

1542

10310

2.76

97.25

10.5

6.6

0.19

e9/l

0.19

1340

9153

(3037522) Nuclear Ab [Titer] in Serum

665

3029

2.73

92.50

1.7

1.4

617.62

502.89

titre

0.81

168

629

(3023420) DNA double strand Ab [Units/volume] in Serum

311

917

3.80

90.66

3.7

1.9

18.10

7.19

iu/ml

3.57

227

(3018418) pH of Serum or Plasma

957

5271

2.47

88.69

6.4

4.0

7.39

7.40

0.70

702

3745

(3013650) Neutrophils [#/volume] in Blood by Automated count

1580

11037

2.63

85.03

13.1

9.3

4.00

4.07

e9/l

0.44

1350

9665

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

683

3290

2.58

83.48

4.7

3.6

250.14

440.05

ng/l

0.92

499

2244

(3030467) Casts [#/volume] in Urine by Automated count

924

5122

2.41

83.03

4.9

3.1

0.43

0.39

e6/l

0.14

677

3708

(3021589) Normoblasts [#/volume] in Blood

1324

8667

2.38

79.97

16.1

10.5

0.00

e9/l

0.48

1030

7122

(3018095) Leukocytes [#/volume] in Urine

1140

7004

2.34

79.83

6.3

3.8

54.13

93.86

e6/l

1.68

816

4776

(3002582) Erythrocytes [#/volume] in Urine

1006

5906

2.32

77.81

5.0

3.2

37.45

78.48

e6/l

1.53

771

4458

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

694

3469

2.48

77.42

3.5

2.7

2.43

mmol/l

0.01

632

3112

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1228

7855

2.32

77.25

10.8

6.3

1.21

mmol/l

0.23

1179

7305

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

9.73

75.50

1.1

88.19

91.48

0.37

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

233

637

3.98

75.16

1.4

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1324

8834

2.30

74.00

11.2

6.9

1.21

mmol/l

0.18

1199

7679

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1822

14084

2.94

72.69

12.4

7.8

77.34

77.07

u/l

0.09

1761

13428

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

600

2875

2.51

72.66

4.3

2.9

2.75

3.07

e6/l

0.35

277

1356

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1390

9538

2.30

71.55

8.0

6.2

11.71

11.00

umol/l

1.11

1333

9107

(3027945) Reticulocytes/Erythrocytes in Blood

440

1830

2.77

70.95

4.2

2.7

1.87

1.77

0.74

403

1660

(3009445) Proteinase 3 Ab [Units/volume] in Serum

249

743

3.66

70.65

1.8

1.5

7.06

10.03

iu/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

110

172

6.69

67.66

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

109

169

6.74

67.59

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

106

162

6.83

66.62

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

108

169

6.68

66.38

1.3

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

862

4995

2.21

65.93

3.6

2.2

2.74

2.72

mg/l

0.05

767

4353

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

107

167

6.69

65.92

1.3

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

110

177

6.50

65.81

1.3

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

230

684

3.65

65.44

3.2

1.8

1.33

1.52

g/l

2.35

205

613

(3018333) Ribosomal P Ab [Presence] in Serum

104

160

6.78

64.95

1.3

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1012

6314

2.14

63.39

4.2

3.3

2.35

mmol/l

0.37

954

5799

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

616

3148

2.34

63.36

4.1

2.8

0.71

1.16

e6/l

1.65

298

1624

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

114

199

5.99

62.86

1.3

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

420

1805

2.65

62.85

3.5

2.5

29.64

65.20

u/l

0.73

359

1516

(3026782) Osmolality of Urine

653

3446

2.29

62.07

3.8

2.8

527.26

525.56

mosm/kgh2o

0.07

579

3026

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

172

440

4.16

60.49

2.4

2.6

0.00

g/l

-0.00

164

414

(3000991) Gas panel - Venous blood

366

1513

2.71

58.89

14.9

9.0

—

(3044640) Blood type and Crossmatch panel - Blood

983

6191

2.08

58.71

3.6

2.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

467

2188

2.45

57.82

3.5

2.8

6.87

7.03

umol/l

0.06

409

1910

(40758558) Short blood count panel - Blood

928

5745

2.08

57.81

8.5

6.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

206

618

3.58

57.65

1.5

1.2

6.00

2.55

u/ml

0.96

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

178

487

3.90

57.00

2.6

2.5

0.16

0.02

g/l

0.46

169

438

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

178

489

3.88

56.67

1.3

1.2

3.05

4.05

u/ml

0.15

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

174

477

3.88

55.54

2.5

0.01

0.00

g/l

0.50

164

415

(3013826) Glucose [Moles/volume] in Serum or Plasma

1456

10721

2.11

55.40

7.9

4.9

6.35

6.53

mmol/l

2.78

1402

10048

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

191

561

3.64

55.13

2.6

2.7

0.43

1.27

g/l

3.09

180

492

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

200

609

3.52

54.65

2.6

3.02

2.96

g/l

0.40

190

561

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

639

3.44

54.00

2.6

2.5

3.65

3.67

g/l

0.09

195

592

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

640

3.44

53.87

2.6

2.5

7.13

7.34

g/l

0.97

195

592

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

640

3.44

53.87

2.6

2.5

4.17

4.23

g/l

0.53

195

591

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

209

668

3.36

52.88

1.4

1.2

69.52

32.36

u/ml

0.73

(3020630) Protein [Mass/volume] in Serum or Plasma

324

1329

2.69

52.57

2.8

2.9

66.16

67.03

g/l

1.29

312

1239

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

186

554

3.58

52.52

2.5

2.6

10.28

10.50

g/l

0.25

175

503

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

200

625

3.43

52.44

1.5

1.3

18.17

8.07

u/ml

0.83

(3020779) Urea [Moles/volume] in Serum or Plasma

349

1489

2.60

52.30

10.3

7.5

9.27

8.89

mmol/l

0.50

333

1433

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

100

7.63

51.90

1.3

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

703

4062

2.09

51.39

3.8

2.6

5.26

6.77

e6/l

2.56

647

3693

(3023368) Bacteria identified in Blood by Culture

761

4551

2.04

50.45

6.8

4.2

—

(3044009) aPTT.lupus sensitive (LA screen)

19.84

50.30

1.5

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1001

6619

1.96

49.49

4.1

3.3

30.96

30.86

u/l

0.02

959

6295

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1400

10374

2.00

49.48

5.1

3.2

105.51

97.72

ug/l

0.50

1344

9831

(3014111) Lactate [Moles/volume] in Serum or Plasma

355

1566

2.52

49.44

12.7

7.6

1.21

1.31

mmol/l

1.31

347

1529

(3005719) IgG [Mass/volume] in Serum or Plasma

350

1560

2.49

47.55

3.5

2.9

10.67

10.70

g/l

0.04

339

1453

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

175

534

3.48

47.53

1.4

1.2

51.00

42.88

u/ml

0.26

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

751

4565

1.99

46.81

3.7

3.0

1176.13

1042.87

ng/l

0.47

645

3842

(3003458) Phosphate [Moles/volume] in Serum or Plasma

453

2276

2.26

46.75

9.5

5.9

1.03

1.05

mmol/l

0.75

430

2119

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

853

5421

1.95

46.66

3.0

2.2

185.79

198.99

u/l

0.18

831

5182

(3004588) Protein electrophoresis panel - Serum or Plasma

267

1053

2.75

46.51

2.5

2.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

765

4689

1.98

46.48

3.5

2.6

347.66

328.70

umol/l

4.91

690

4202

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

8.74

45.71

1.4

1.0

—

(3019174) dRVVT (LA screen)

17.10

44.53

1.5

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

751

4649

1.95

43.75

3.6

2.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

251

989

2.74

43.69

13.3

10.1

24.01

24.27

mmol/l

0.66

246

970

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1236

8996

1.88

43.48

3.8

2.7

—

estimate

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1579

12464

2.01

43.30

6.0

4.4

769.40

2372.82

e6/l

1.21

151

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

417

2090

2.24

42.94

2.2

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

155

470

3.48

42.44

3.6

3.1

2.76

2.10

index

0.61

254

(3028026) IgM [Mass/volume] in Serum or Plasma

287

1228

2.54

42.26

2.2

1.9

1.45

1.46

g/l

0.02

276

1144

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

115

286

4.19

41.84

1.3

1.2

6.38

12.20

u/ml

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1713

14026

2.09

40.94

6.7

4.2

11.96

10.79

mm/h

2.82

1654

13247

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

10.20

40.77

1.7

1.1

89.83

96.93

0.63

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

398

2004

2.21

40.30

2.2

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

510

2851

2.03

39.14

2.2

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

710

4461

1.88

38.51

1.9

1.5

2.28

g/l

0.01

452

2901

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

242

997

2.61

38.38

1.9

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

109

278

4.08

38.32

1.3

84.84

65.58

u/ml

—

(3023520) Reticulocytes [#/volume] in Blood

301

1378

2.38

38.05

4.1

2.7

77.36

70.70

e9/l

1.35

157

1007

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

199

760

2.78

36.59

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

143

457

3.28

35.96

3.0

3.7

3.69

3.17

ratio

0.11

270

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

153

512

3.14

35.65

3.3

3.9

31.28

41.86

mg/l

0.86

135

449

(3034860) Kappa light chains.free [Mass/volume] in Serum

153

513

3.13

35.53

3.3

3.9

45.95

67.20

mg/l

0.80

135

450

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1877

16182

2.27

35.27

35.8

17.1

13.74

13.47

13.07

1871

15983

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

338

1675

2.21

35.26

2.8

2.3

0.22

g/l

0.10

321

1573

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1183

8831

1.76

34.93

3.4

2.5

76.40

75.84

nmol/l

0.29

1116

8161

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

287

1337

2.32

34.70

5.6

3.9

101.01

81.81

ng/l

2.05

262

1189

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

115

328

3.65

34.50

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

115

328

3.65

34.50

1.2

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

164

582

2.97

34.49

3.7

2.1

292.16

373.00

ug/l

0.34

156

546

(3042936) Bacteria identified in Isolate by Culture

461

2588

1.99

34.45

2.4

2.0

—

(3003396) Base excess in Arterial blood by calculation

359

1865

2.11

33.05

11.2

8.5

0.17

0.92

mmol/l

2.64

312

1526

(3027801) Oxygen [Partial pressure] in Arterial blood

363

1895

2.10

32.99

11.3

8.4

12.91

12.68

kpa

0.33

353

1824

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

363

1895

2.10

32.99

11.3

8.4

5.01

5.10

kpa

1.09

354

1821

(3019977) pH of Arterial blood

361

1890

2.09

32.52

11.2

8.5

7.43

7.41

1.62

140

1048

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1068

7876

1.71

31.78

2.5

2.0

96.58

96.92

pmol/l

0.08

634

4272

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

292

1430

2.21

31.15

3.0

2.7

77.05

71.10

ml/min/173m2

2.41

194

591

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

249

1142

2.34

31.07

3.3

3.0

222.09

174.01

ng/l

0.72

221

1039

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

127

416

3.18

30.64

1.5

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

120

387

3.23

29.70

1.5

1.4

148.25

150.61

au/ml

0.06

114

(3014051) Protein [Presence] in Urine by Test strip

824

5744

1.71

29.57

3.6

2.8

0.00

0.02

0.50

(3016502) Oxygen saturation in Arterial blood

321

1672

2.08

29.10

12.3

9.0

96.43

95.83

1.40

312

1621

(3021447) Carbon dioxide [Partial pressure] in Venous blood

333

1760

2.06

29.02

7.3

3.7

5.84

5.83

kpa

0.11

322

1710

(3002032) Base excess in Venous blood by calculation

324

1697

2.07

28.93

7.4

3.8

1.33

1.83

mmol/l

1.63

292

1462

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2047

18685

3.05

28.30

27.4

14.0

22.80

21.94

mg/l

0.61

1828

15270

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

150

567

2.77

28.02

5.0

4.5

1.53

1.41

mg/l

0.82

145

527

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

631

4137

1.74

27.96

1.9

1.7

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1977

17773

2.42

27.78

26.2

13.0

86.23

86.50

ml/min/173m2

0.22

1871

16295

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

261

1280

2.18

27.59

1.7

—

(44806071) Cardiolipin IgM antibody measurement

10.13

27.41

1.3

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

332

1795

2.00

27.04

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

723

4971

1.69

26.66

2.1

—

(3012544) pH of Venous blood

326

1761

2.00

26.59

7.3

3.8

7.37

7.38

1.37

180

1015

(3017143) Hepatitis C virus Ab [Presence] in Serum

447

2688

1.84

26.34

1.8

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

718

5002

1.65

24.76

2.0

1.6

18.61

20.31

nmol/l

3.07

637

4336

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

141

554

2.65

24.40

1.2

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2030

18630

2.64

24.37

29.6

15.6

139.49

139.62

mmol/l

1.89

2018

18279

(3023103) Potassium [Moles/volume] in Serum or Plasma

2033

18671

2.67

24.37

30.2

15.7

3.94

mmol/l

0.59

2019

18283

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

305

3.25

24.36

1.7

1.4

—

(3015736) pH of Urine

1073

8268

1.60

24.32

3.8

3.3

6.21

0.07

553

4746

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

153

4.21

23.67

1.3

1.1

120.00

258.70

titre

—

(3007853) Bacteria identified in Skin by Aerobe culture

381

2251

1.84

23.52

2.4

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

252

3.43

23.35

1.1

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

872

6483

1.58

22.45

4.0

3.4

37.96

51.01

ng/l

0.43

519

4028

(3021601) Nitrite [Presence] in Urine by Test strip

1263

10221

1.57

22.36

4.7

3.7

0.00

estimate

0.80

296

2157

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

5.62

22.29

1.8

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

5.62

22.29

1.8

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

661

4611

1.63

22.17

4.1

3.6

0.00

0.19

—

(3035350) Ketones [Presence] in Urine by Test strip

1271

10338

1.56

21.69

4.7

3.7

25.13

4.37

estimate

1.16

304

2183

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

187

3.72

21.55

1.2

51.71

52.38

u/ml

—

(3009261) Glucose [Presence] in Urine by Test strip

1275

10404

1.56

21.24

4.7

3.7

0.01

0.15

estimate

0.49

291

2076

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

106

391

2.80

20.73

7.7

5.8

256.64

291.51

iu/ml

0.13

(3000494) Fungus identified in Specimen by Culture

383

2348

1.77

20.68

1.8

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.87

20.58

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

303

1733

1.87

20.55

4.3

2.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.91

19.69

1.3

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

5.43

19.50

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

267

3.11

19.36

2.6

2.5

25.90

39.29

iu/ml

—

(3024354) Oxygen [Partial pressure] in Venous blood

266

1487

1.90

19.30

6.0

3.2

4.71

4.63

kpa

0.25

254

1441

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

125

521

2.49

19.15

1.8

2.2

12.34

11.46

mg/l

0.54

118

490

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

110

439

2.59

18.45

1.4

1.3

272.26

255.64

u/ml

0.14

262

(40768804) Tissue Pathology biopsy report

982

7720

1.50

18.39

2.3

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

347

2.79

18.37

1.6

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

708

5218

1.53

17.91

1.4

1.3

0.88

1.53

u/ml

2.37

162

1479

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

173

852

2.12

17.91

1.9

2.1

39.33

39.39

u/l

0.01

153

773

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1929

17702

1.88

17.46

6.6

5.5

1.81

1.83

mu/l

0.26

1858

16712

(3036481) Cortisol [Moles/volume] in Serum or Plasma

331

2039

1.74

17.35

2.5

2.1

350.29

378.28

nmol/l

1.74

314

1903

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

113

472

2.47

17.25

1.8

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

350

2.70

16.99

1.8

1.6

0.67

0.70

g/l

0.11

274

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

569

4042

1.55

16.82

1.4

1.3

22.26

27.59

iu/ml

0.91

156

1204

(3002256) Pathology report gross observation

382

2469

1.67

16.72

1.4

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

242

3.04

16.68

1.4

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

218

3.14

16.40

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

127

577

2.28

16.05

1.3

1.2

95.00

88.71

titre

—

(3051611) Lipemic interference index of Serum or Plasma

157

3.50

15.82

4.5

3.2

13.72

13.50

index

0.05

103

(3048929) Epstein Barr virus Ab [Presence] in Serum

155

778

2.07

15.25

1.4

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

979

7881

1.45

15.22

2.1

1.9

1.37

1.36

mmol/l

0.15

867

6830

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

109

475

2.36

15.17

1.1

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

760

5867

1.46

14.60

3.1

2.6

55.88

72.59

u/l

0.65

716

5475

(40768797) Stomach Pathology biopsy report

390

2620

1.60

14.43

1.3

1.2

—

(3035933) Granulocytes/Leukocytes in Blood

101

436

2.38

14.37

3.8

3.2

58.34

58.05

0.08

101

436

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

339

2.57

14.32

1.8

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

124

593

2.16

13.84

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2064

19638

2.32

13.23

18.4

11.1

27.20

25.53

u/l

2.69

2035

19177

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1541

13659

1.45

13.19

4.1

3.4

—

(3042733) HLA Ab [Presence] in Serum

4.96

13.11

4.6

4.7

—

(3045142) Bone marrow Pathology biopsy report

181

3.03

12.63

1.3

—

(3012501) Base excess in Blood by calculation

331

2.47

12.52

5.6

4.1

2.06

2.39

mmol/l

0.51

218

(3002179) Metamyelocytes/Leukocytes in Blood

259

1629

1.67

12.38

5.3

4.3

0.75

0.67

0.20

430

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

507

3715

1.48

12.37

1.3

10.70

11.00

u/ml

0.03

150

1534

(3037756) Immunofixation for Serum or Plasma

333

2.46

12.36

1.8

1.7

—

(3022145) Colonoscopy Study observation

323

2156

1.59

12.14

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

384

2668

1.53

12.08

2.0

1.7

1000.86

1180.24

nmol/l

4.07

312

2050

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.70

11.89

1.7

3.0

0.61

0.62

mmol/l

0.33

(36660697) Celiac disease serology panel - Serum

273

1758

1.63

11.88

1.3

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2066

19738

2.24

11.85

32.1

17.3

77.26

73.06

umol/l

4.43

2058

19537

(3000093) Morphology [Interpretation] in Blood Narrative

141

3.24

11.79

1.3

1.1

—

(3025159) Blasts/Leukocytes in Blood

260

1659

1.65

11.73

5.9

4.8

0.06

0.32

0.62

351

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1524

13596

1.42

11.67

3.9

3.2

46.40

41.74

u/l

1.37

1461

12971

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

226

1394

1.69

11.61

3.3

3.7

4.39

4.55

pmol/l

1.95

204

1264

(3048689) Calprotectin [Mass/mass] in Stool

409

2904

1.50

11.58

2.5

118.78

112.66

ug/g

0.15

332

2323

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

164

3.03

11.52

5.7

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1691

15391

1.46

11.47

5.4

4.6

14.51

14.54

pmol/l

0.21

1611

14404

(1002224) Polysomnography panel

183

1069

1.78

11.40

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

106

518

2.10

11.23

2.4

2.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

312

2.42

11.15

1.9

1.3

21.47

23.93

u/l

0.17

266

(3024471) HLA-A [Type]

4.67

10.95

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

169

2.94

10.95

11.3

6.4

6.89

6.95

mmol/l

0.05

139

(3003694) ABO and Rh group [Type] in Blood

754

6043

1.38

10.92

1.7

1.6

—

(3021440) Promyelocytes/Leukocytes in Blood

254

1642

1.62

10.86

5.8

4.5

0.12

0.11

0.05

387

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

113

3.41

10.83

1.3

1.5

4.95

6.27

u/l

0.95

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

113

3.41

10.83

1.7

2.7

550.71

953.15

u/ml

1.60

113

(21494434) Karyotype in Bone marrow

125

3.24

10.56

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

3.72

10.42

1.5

1.4

13.50

13.81

u/l

0.08

(3010375) cycloSPORINE [Mass/volume] in Blood

3.89

10.39

26.3

29.4

109.58

122.27

ug/l

0.43

(3017181) Myelocytes/Leukocytes in Blood

260

1712

1.59

10.28

5.8

4.5

0.86

0.98

0.31

457

(3024932) HLA-DR beta [Type]

4.57

10.24

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1842

17159

1.52

10.14

6.6

5.7

38.29

38.34

mmol/mol

0.09

1766

16278

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

159

2.87

9.66

1.3

1.2

69.40

38.43

u/ml

—

(3009508) Creatinine [Moles/volume] in Urine

743

6032

1.35

9.63

4.6

3.5

7.20

7.80

mmol/l

3.07

653

5220

(3003327) Ova and parasites identified in Stool by Light microscopy

143

819

1.80

9.54

1.9

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

221

1427

1.61

9.47

2.4

2.5

15.17

21.15

au/ml

0.99

179

(3023183) Ammonium ion [Moles/volume] in Plasma

355

2.18

9.09

4.3

2.9

35.70

33.60

umol/l

0.43

323

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

311

2.26

9.00

1.7

1.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

122

680

1.84

8.90

1.4

1.5

0.04

0.17

iu/ml

0.74

104

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

135

2.92

8.71

2.4

2.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

355

2.15

8.69

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

152

2.80

8.66

3.2

3.6

—

(40761511) CBC panel - Blood by Automated count

2025

19402

1.77

8.64

20.8

12.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

203

1314

1.60

8.61

1.3

47.88

42.41

au/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

230

1540

1.55

8.43

1.5

1.3

149.75

270.91

u/ml

1.17

222

1430

(40768443) Skin Pathology biopsy report

132

770

1.76

8.30

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

215

2.45

8.25

1.5

1.4

0.31

0.39

g/l

1.33

151

(3028192) IgG subclass 2 [Mass/volume] in Serum

215

2.45

8.25

1.6

1.4

2.47

2.93

g/l

1.36

153

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

154

940

1.69

8.23

2.1

1.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

404

2.04

8.21

2.7

2.3

133.59

131.48

g/l

0.33

328

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1938

18400

1.55

8.18

5.5

4.7

4.48

4.70

mmol/l

19.22

1860

17470

(3027135) IgG subclass 1 [Mass/volume] in Serum

216

2.44

8.18

1.6

1.4

7.09

6.62

g/l

0.34

154

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.38

8.15

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

352

2.11

8.09

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

17.23

8.07

1.3

1.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

300

2.20

8.04

1.5

1.2

97.50

380.91

titre

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

224

2.40

8.03

1.5

1.6

—

(40761536) Microorganisms panel - Urine sediment

237

1616

1.52

7.99

5.5

3.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1953

18595

1.56

7.89

6.4

5.2

2.61

2.78

mmol/l

15.27

1872

17581

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

495

1.92

7.85

1.7

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

474

1.94

7.84

1.7

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1929

18323

1.52

7.82

5.5

4.6

1.41

1.48

mmol/l

10.01

1840

17301

(3012516) Albumin [Mass/volume] in Urine

653

5329

1.32

7.81

4.6

3.5

71.54

49.31

mg/l

1.18

450

3432

(3023410) Appearance of Cerebral spinal fluid

227

2.37

7.81

1.6

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

102

562

1.86

7.75

1.2

—

(1616796) Gas panel - Central venous blood

373

2.05

7.68

5.7

3.7

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

7.44

7.67

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

189

1239

1.58

7.60

1.9

2.3

10.65

7.30

ug/l

0.85

162

1110

(3020682) Albumin/Creatinine [Ratio] in Urine

661

5425

1.32

7.54

5.6

4.2

11.79

8.82

mg/mmol

0.91

442

3440

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

10.06

7.53

1.4

1.6

0.62

0.74

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

10.06

7.53

1.4

1.6

4.23

2.35

mg/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

108

2.99

7.51

1.3

1.2

1511.11

1022.73

titre

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1845

17402

1.43

7.48

4.6

4.0

1.29

1.26

mmol/l

0.98

1747

16316

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

7.13

7.47

1.9

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

101

563

1.83

7.41

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

239

2.29

7.40

1.5

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

203

1366

1.54

7.28

4.9

3.3

1.22

1.23

mmol/l

0.71

185

1172

(40760892) CBC W Ordered Manual Differential panel - Blood

588

4768

1.32

7.27

6.7

4.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

101

570

1.81

7.13

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

398

1.97

7.11

3.0

2.4

4.99

5.06

umol/l

0.05

295

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

218

2.32

7.11

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

263

2.20

7.09

1.6

1.5

21.69

23.91

ng/l

0.41

263

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.17

6.99

1.1

157.97

172.17

iu/ml

0.14

(21494890) Protein electrophoresis panel - 24 hour Urine

165

2.51

6.94

2.0

2.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.54

6.89

13.4

8.3

6.70

6.12

mmol/l

0.14

(3003434) Protein [Mass/volume] in Pleural fluid

172

2.47

6.86

1.5

1.4

31.92

32.41

g/l

0.08

156

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

228

2.27

6.86

1.1

1.3

0.18

0.17

nmol/l

0.26

166

(3006922) Hepatitis E virus Ab [Presence] in Serum

155

2.54

6.78

1.2

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

204

1397

1.51

6.74

1.7

1.5

—

(40768446) Kidney Pathology biopsy report

3.41

6.70

1.8

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

573

4677

1.31

6.66

1.8

1.7

—

(3012441) Differential panel - Pleural fluid

133

2.66

6.65

1.6

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1858

17618

1.41

6.64

5.4

4.6

5.77

5.80

mmol/l

0.39

1752

16451

(4027681) Cerebrospinal fluid IgG ratio and IgG index

151

2.54

6.61

1.2

0.77

0.64

ratio

0.36

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

145

924

1.61

6.59

1.7

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

440

1.87

6.48

1.4

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

203

2.29

6.39

2.5

2.1

31.46

32.26

0.50

203

(4062490) Immunoglobulin typing, IgG

216

2.25

6.38

1.6

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

125

2.67

6.32

1.6

1.4

212311.86

86972.46

e6/l

0.25

(3045788) Cell count panel - Pleural fluid

125

2.67

6.32

1.7

1.4

—

(3008898) HLA-B27 [Presence]

139

890

1.60

6.21

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

12.55

6.08

1.0

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

105

2.79

6.06

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

473

1.81

6.02

1.4

1.5

35.77

31.12

e6/l

0.07

353

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

150

986

1.56

6.00

5.8

3.7

1.40

1.66

mmol/l

0.38

109

732

(3023199) Leukocytes [#/volume] in Pleural fluid

147

2.47

5.95

1.6

1.3

1270.15

2043.40

e6/l

1.25

(3049717) Cytology report of Urine Cyto stain

536

1.75

5.89

2.3

2.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

124

2.60

5.88

1.5

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

284

2.03

5.88

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

168

1139

1.52

5.84

5.9

3.8

5.09

5.14

kpa

0.40

161

1095

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

186

2.28

5.82

1.4

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

125

2.58

5.80

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

101

607

1.70

5.79

3.5

75.65

2522.11

u/ml

0.88

528

(3000012) Reticulocyte production index

213

2.19

5.74

3.1

2.0

1.05

0.88

1.08

137

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

481

1.78

5.71

1.5

291.06

1378.78

e6/l

1.06

382

(3011412) CD3 cells [#/volume] in Blood

175

2.31

5.70

2.4

2.6

1122.88

1317.22

e6/l

0.66

156

(3017732) Neutrophils [#/volume] in Blood

328

2524

1.35

5.67

3.4

3.0

4.34

4.68

e9/l

0.56

299

2256

(3020876) Protein [Mass/time] in 24 hour Urine

208

2.19

5.64

2.0

2.5

1.09

1.25

g/24h

0.19

124

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

183

2.26

5.59

1.1

199.92

230.44

mg/l

0.81

160

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

191

1342

1.46

5.58

2.8

2.3

4134.17

5864.91

u/l

0.55

537

(1175426) CD3 cells/Lymphocytes in Blood

140

2.45

5.54

2.2

2.3

72.35

73.69

0.16

135

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

141

2.43

5.46

1.1

1.00

1.08

u/l

0.77

(3037121) Protein [Mass/volume] in Urine

102

627

1.66

5.40

4.1

3.9

660.86

302.13

mg/l

0.45

269

(3019832) Treponema pallidum Ab [Presence] in Serum

389

3094

1.31

5.35

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

439

1.78

5.34

1.6

1.4

—

(3009343) pH of Capillary blood

162

1112

1.49

5.33

6.0

3.8

7.42

0.00

140

943

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

337

2629

1.33

5.31

1.8

1.41

1.43

0.26

299

2335

(3004809) Band form neutrophils/Leukocytes in Blood

234

2.08

5.28

3.0

3.2

1.01

1.52

0.75

217

(3000475) Leukocytes [#/volume] in Synovial fluid

426

1.79

5.27

1.4

1.7

15230.65

13637.42

e6/l

0.07

297

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

112

713

1.60

5.17

1.4

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.37

5.14

1.2

1.3

0.83

0.29

iu/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

612

1.65

5.14

1.2

1.1

3.51

3.83

0.24

(3003329) Lymphocytes/Leukocytes in Synovial fluid

133

2.43

5.13

1.6

1.5

31.32

34.50

0.16

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.34

5.08

1.3

1.96

1.24

iu/ml

—

(3041096) Erythrocytes [Presence] in Urine by Automated

675

5783

1.24

5.04

4.1

3.1

0.04

0.20

estimate

0.53

240

1744

(3022621) pH of Urine by Test strip

213

1557

1.41

5.04

2.5

2.3

6.03

6.11

0.64

134

1026

(3000570) Elastase.pancreatic [Mass/mass] in Stool

554

1.67

5.02

1.5

1.4

276.55

296.69

ug/g

0.39

313

(3032773) Endomysium IgG Ab [Titer] in Serum

233

2.04

4.97

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.03

4.91

2.2

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

230

1714

1.38

4.86

1.3

1.2

203.62

145.72

u/ml

0.89

670

(3023419) Bacteria identified in Sputum by Culture

229

2.03

4.82

3.4

2.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

2.59

4.80

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

150

2.29

4.80

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

447

1.73

4.77

1.3

1.4

—

(3025941) Bacteria identified in Stool by Culture

166

1174

1.45

4.72

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

159

2.22

4.63

2.9

2.1

23.03

30.39

mg/l

0.66

106

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

354

1.80

4.62

1.6

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

199

2.08

4.60

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

116

766

1.54

4.60

1.4

10.29

10.04

u/l

0.07

615

(3003181) Sodium [Moles/volume] in Urine

304

1.86

4.59

1.6

1.4

69.40

62.82

mmol/l

0.44

256

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

319

2521

1.31

4.57

2.1

1.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

180

2.13

4.55

1.4

1.7

52.63

56.54

0.23

116

(3030981) Hyaline casts [#/volume] in Urine by Automated count

194

1424

1.40

4.49

3.5

2.5

0.30

0.41

e6/l

0.31

187

1354

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.84

4.49

1.3

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

181

2.12

4.49

1.1

—

(3007461) Platelets [#/volume] in Blood

2090

20479

1.77

4.48

41.2

21.5

250.09

258.73

e9/l

6.96

2064

20153

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

548

1.63

4.48

1.2

1.3

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2090

20485

1.76

4.39

41.1

21.4

90.71

90.61

0.41

2085

20325

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

225

1700

1.36

4.37

1.6

942.97

1017.98

mu/l

0.59

182

1410

(3035941) MCH [Entitic mass]

2090

20487

1.76

4.36

41.1

21.4

30.09

30.20

2.04

2085

20326

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2090

20487

1.76

4.36

42.8

21.8

39.91

40.39

5.06

2085

20317

(3026361) Erythrocytes [#/volume] in Blood

2090

20488

1.76

4.34

41.2

21.4

4.46

4.51

e12/l

3.75

2061

20116

(3010813) Leukocytes [#/volume] in Blood

2090

20490

1.75

4.31

41.2

21.5

6.79

6.76

e9/l

0.25

2060

20108

(40768806) Pleura Pathology biopsy report

139

2.25

4.25

1.8

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

2090

20496

1.74

4.22

41.6

21.6

132.70

135.20

g/l

13.83

2085

20333

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

120

815

1.50

4.21

1.9

1.6

10.69

11.46

u/ml

0.13

217

(3017446) Testosterone [Moles/volume] in Serum or Plasma

185

1363

1.39

4.20

2.4

2.3

11.18

12.23

nmol/l

1.01

167

1242

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

139

979

1.45

4.07

1.5

57.65

60.49

ug/l

0.27

114

812

(4035726) Immunohistochemistry procedure

201

1512

1.36

4.03

1.5

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

260

1.87

4.00

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

260

1.87

4.00

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

260

1.87

4.00

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

260

1.87

4.00

1.6

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

158

1145

1.41

3.96

1.1

—

95.87

—

(3000060) B lymphocytes [#/volume] in Blood

2.83

3.96

1.5

2.2

0.18

0.23

e9/l

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

131

2.23

3.93

1.7

2.7

532.56

551.78

e6/l

0.06

109

(3034891) Synovial lining cells/cells in Synovial fluid

2.73

3.92

1.2

1.3

4.67

4.62

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

130

912

1.45

3.90

1.5

1.12

1.15

ratio

0.14

542

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

130

913

1.45

3.88

1.5

1.27

1.19

ratio

0.33

546

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

130

913

1.45

3.88

1.5

1.00

0.95

ratio

0.50

543

(3021387) Prolactin [Units/volume] in Serum or Plasma

153

1109

1.41

3.84

1.4

1.7

280.69

293.26

mu/l

0.23

138

999

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

128

899

1.45

3.82

1.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

454

1.63

3.78

1.4

3.36

3.29

ug/l

0.04

415

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

12.03

3.76

1.2

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

5.64

3.66

1.2

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

351

1.70

3.63

1.1

1.31

2.03

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.87

3.63

1.3

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

212

1635

1.33

3.62

1.4

24.70

24.34

iu/l

0.06

177

1395

(3045414) Leukocytes [Presence] in Urine

229

1793

1.31

3.52

2.3

2.0

0.03

0.01

estimate

0.26

393

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

118

830

1.45

3.52

2.4

2.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

632

1.51

3.51

1.7

2.2

2.70

12.61

iu/l

0.60

270

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

138

2.12

3.49

1.7

2.7

179.33

211.28

e6/l

0.50

121

(3047189) Immunofixation for 24 hour Urine

2.55

3.46

1.8

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

106

2.28

3.45

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

259

1.79

3.44

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

127

911

1.42

3.41

2.1

1.6

0.29

0.31

mg/l

0.17

414

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

209

1625

1.32

3.39

3.5

4.3

5.22

22.68

ug/l

2.06

150

1281

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.51

3.38

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

175

1.96

3.34

1.5

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

470

1.57

3.32

1.3

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.59

3.26

2.2

4.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

8.59

3.26

1.7

2.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

277

2246

1.27

3.26

1.9

2.1

—

(3035880) pH of Pleural fluid

2.51

3.21

1.4

1.2

7.36

7.38

0.11

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.51

3.21

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

140

1869

0.73

3.20

5.2

6.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

110

2.20

3.19

1.8

1.5

2.05

6.30

u/l

1.98

(3050129) First trimester maternal screen panel - Serum or Plasma

150

1121

1.36

3.18

1.6

1.5

—

(3010937) Rubella virus Ab [Presence] in Serum

4.51

3.11

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.81

3.08

1.6

—

(4034850) Laboratory test

569

0.54

3.04

7.6

9.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

203

1.84

3.04

1.4

1.2

3.42

2.08

u/ml

0.27

108

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.85

3.02

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

332

1.64

2.99

1.1

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

10.02

2.98

1.0

7.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

357

1.61

2.94

1.1

4.02

2.27

eliau/ml

0.23

173

(3050794) Legionella sp Ab [Presence] in Serum

4.72

2.92

1.3

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

296

2453

1.24

2.89

3.1

3.0

0.74

0.72

ug/l

0.13

191

1493

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

6.68

2.87

1.7

3.9

95.67

97.44

g/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.17

2.85

1.6

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

106

763

1.41

2.84

1.5

—

(3025130) Human papilloma virus identified in Specimen

450

1.53

2.79

1.8

—

(3005033) Fetal Nuchal fold Thickness US

104

749

1.41

2.79

1.5

1.23

1.27

0.37

528

(3043238) Trisomy 21 risk [Likelihood] in Fetus

108

783

1.40

2.78

1.5

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

277

1.68

2.78

1.2

1.1

1.51

1.49

g/l

0.13

258

(3004716) Salmonella sp identified in Stool by Organism specific culture

151

1158

1.33

2.74

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

404

1.55

2.73

5.0

2.4

0.94

0.86

nmol/l

0.33

343

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.01

2.70

1.7

4.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

168

1.86

2.67

1.1

1.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

147

1.92

2.65

2.5

1.6

—

(3042631) Mycobacterium sp identified in Specimen

206

1.76

2.62

3.1

2.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

344

2926

1.21

2.61

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

607

1.43

2.59

3.0

1.9

1.33

1.68

ug/l

0.23

541

(3000330) Specific gravity of Urine by Test strip

115

854

1.37

2.59

2.9

3.1

1.02

ratio

0.64

778

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.07

2.56

4.2

7.2

5.84

5.16

kpa

0.25

(21494755) Public health laboratory ask at order entry panel

182

2269

0.78

2.56

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.14

2.55

1.1

1.4

163.75

161.31

mmol/24h

0.05

(3001893) Eosinophils/Leukocytes in Pleural fluid

2.74

2.54

1.3

1.00

2.49

0.49

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

576

1.44

2.54

2.0

1.8

41.26

40.91

nmol/l

0.04

561

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.47

2.54

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.47

2.54

1.0

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

5.47

2.54

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.47

2.54

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

246

1.68

2.54

1.5

1.4

298.53

421.39

pmol/l

1.24

215

(3017704) Immunofixation for Urine

2.17

2.51

1.4

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

3.47

2.48

1.2

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.39

2.47

1.1

1.3

4.29

9.25

u/l

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

4.39

2.47

1.6

1.8

170.14

143.69

ug/g

—

(3023511) Choriogonadotropin [Units/volume] in Urine

673

1.40

2.46

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.68

2.45

1.1

1.8

0.18

0.15

nmol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

615

1.41

2.43

1.1

4.21

4.75

eliau/ml

0.09

(3032868) Hemoglobin electrophoresis panel in Blood

3.34

2.39

1.3

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.34

2.39

1.2

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

111

1.99

2.35

1.6

1.3

129.14

138.35

nmol/l

0.63

111

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.04

2.35

1.3

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.32

2.31

3.0

2.2

28.33

28.18

0.01

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

105

2.01

2.31

1.6

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.95

2.28

1.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

254

1.63

2.28

2.8

3.6

0.80

0.84

nmol/l

0.23

212

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.76

2.27

1.0

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

157

1245

1.28

2.27

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.49

2.27

1.1

1.3

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.90

2.25

1.4

1.6

22.57

13.78

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

425

1.47

2.22

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

172

1.75

2.21

1.2

1.1

118.83

110.19

pmol/l

0.47

172

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

100

2.01

2.20

1.6

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

107

1.97

2.20

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.42

2.20

1.5

1.2

—

(3045424) Erythrocytes [Presence] in Urine

119

914

1.32

2.19

2.5

2.1

0.00

0.81

estimate

0.50

311

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

122

1.89

2.16

1.5

2.7

39.86

44.86

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.30

2.14

2.1

1.4

—

(3033099) Centromere Ab [Titer] in Serum

2.79

2.13

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

212

1.66

2.13

1.5

1.7

287.88

280.98

mosm/kgh2o

1.26

167

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

364

3172

1.18

2.12

2.2

2.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.21

2.09

1.0

0.32

0.44

u/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.14

2.08

1.4

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.27

2.07

5.0

4.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

146

1.79

2.06

2.5

2.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

874

0.70

2.06

1.1

0.61

0.65

ratio

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

4.01

2.04

1.0

1.1

—

24.14

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.01

2.04

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

2.51

2.01

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

2.82

2.00

1.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.15

1.98

1.1

1.3

92.89

93.12

nmol/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.45

1.93

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.32

1.87

1.8

1.2

—

(3022313) Gas panel - Capillary blood

102

786

1.31

1.87

6.9

4.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.65

1.86

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

841

7828

1.12

1.86

4.2

3.6

0.00

0.10

estimate

1.06

250

1802

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

105

814

1.30

1.85

1.5

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

395

3503

1.16

1.84

2.4

2.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

924

0.73

1.84

1.1

1.60

1.55

g/l

0.65

924

(3011288) Drugs identified in Urine by Screen method Nominal

103

797

1.31

1.84

3.9

2.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.21

1.84

1.4

2.0

42.36

41.07

g/l

0.42

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.17

1.82

1.4

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

1.89

1.81

1.1

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.76

1.79

2.8

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

362

1.45

1.77

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.35

1.77

1.7

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.92

1.72

2.0

2.8

—

18.82

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

202

1.59

1.71

1.7

2.5

16.62

20.48

nmol/l

1.85

195

(4094501) Cardiovascular stress test using bicycle ergometer

510

1.36

1.69

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.01

1.69

4.5

3.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

203

1.59

1.68

3.9

5.1

219.72

76.73

u/ml

0.33

(3028679) Herpes simplex virus Ab [Presence] in Serum

141

1.71

1.68

1.0

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

520

1.36

1.67

1.6

1.4

0.59

0.44

nmol/l

0.21

413

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.81

1.65

1.0

91.43

65.28

titre

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

142

1.70

1.64

1.5

1.4

—

(3044007) Cell count panel - Peritoneal fluid

2.25

1.63

2.0

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

369

1.42

1.63

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

174

1.62

1.61

2.2

1.5

234.38

914.19

pmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

171

2032

0.83

1.60

4.7

4.5

33.05

31.84

0.71

133

1432

(3036071) Salmonella sp Ab [Titer] in Serum

1.91

1.59

1.3

1.1

—

(3001556) Androgen free Index in Serum or Plasma

2.70

1.58

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

191

1.58

1.57

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

114

1.76

1.56

1.6

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

444

4017

1.13

1.55

4.9

5.1

2.33

2.41

ug/l

0.07

407

3646

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

232

1.52

1.54

1.1

1.3

—

nmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

167

1401

1.21

1.53

1.3

1.2

—

(4198724) Urine methamphetamine measurement

100

1.81

1.53

3.2

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

214

1841

1.18

1.49

1.9

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

385

1.39

1.48

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

144

1196

1.22

1.47

2.0

2.8

29.85

60.96

u/ml

1.72

139

1157

(44813793) Dust mix specific IgE antibody measurement

155

1.62

1.47

1.2

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.23

1.46

3.2

4.89

4.82

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.23

1.46

3.2

11.37

10.36

kpa

—

(37021550) Renin [Units/volume] in Plasma --upright

2.37

1.45

1.0

1.3

31.56

65.92

mu/l

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

650

1.29

1.42

7.2

4.1

24.35

24.73

mmol/l

0.75

606

(1761868) Lipid panel - Serum or Plasma

764

8132

0.91

1.41

3.0

2.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

432

1.35

1.40

1.2

1.1

7.32

18.24

au/ml

1.86

116

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

948

0.77

1.39

1.1

1.2

0.90

0.88

g/l

0.22

948

(3013637) Mi-2 Ab [Presence] in Serum

2.01

1.38

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.01

1.38

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.01

1.38

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.01

1.38

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

150

1.61

1.38

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.61

1.36

1.0

—

(3004451) EKG impression Narrative

1.76

1.35

1.2

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

470

1.33

1.35

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

151

1.60

1.35

1.2

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

453

1.33

1.34

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

160

1.57

1.31

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

121

1.66

1.30

1.4

2.1

2.15

2.03

u/field

0.05

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.30

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

110

906

1.23

1.25

1.4

1.3

225.26

221.46

miu/ml

0.03

457

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

253

1.43

1.24

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

468

1.31

1.24

1.2

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.97

1.22

1.1

1.3

4.96

0.59

u/ml

0.41

(3047181) Lactate [Moles/volume] in Blood

496

1.30

1.21

5.0

7.5

1.33

1.27

mmol/l

0.16

433

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.64

1.21

1.2

1.0

0.83

0.42

u/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.64

1.21

3.0

2.2

—

(4281824) Cell count and differential, peritoneal fluid

213

1.46

1.20

1.1

—

(3042517) Benzodiazepines panel - Urine

2.31

1.18

1.7

—

(4024509) Urine culture

102

840

1.22

1.18

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

173

1.51

1.18

1.0

1.1

9.80

9.26

iu/ml

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

165

1.52

1.17

3.9

2.1

—

(40768441) Liver Pathology biopsy report

149

1.55

1.17

1.9

1.5

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.06

1.15

1.0

1.2

2.72

5.01

nmol/l

—

(4211845) Urine protein measurement

1.73

1.15

2.4

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

345

1.34

1.11

1.2

1.1

13.20

1634.53

iu/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.26

1.10

1.1

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

193

1.46

1.09

1.0

1.1

16.93

15.99

u/ml

0.06

(3029937) Albumin [Presence] in Urine by Test strip

594

5569

1.09

1.06

4.9

3.8

0.00

0.01

estimate

1.94

282

2052

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.67

1.04

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.67

1.04

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.67

1.04

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.67

1.04

1.8

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.28

1.03

3.0

2.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

138

1.53

1.03

1.1

0.09

1.65

nmol/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

214

1.41

0.99

1.1

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

292

1.34

0.98

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

140

1.50

0.97

1.3

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.95

0.97

1.1

1.4

64.14

67.33

ug/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

103

871

1.19

0.95

2.4

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

217

1.39

0.93

1.1

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

217

1.39

0.93

1.1

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

184

1.42

0.91

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.63

0.91

2.4

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

168

1.43

0.89

3.0

3.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

611

1.22

0.89

1.2

1.1

1.21

2.53

u/ml

1.09

328

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.69

0.88

1.3

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.61

0.87

2.9

2.7

1.61

1.09

ug/l

0.22

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.82

0.86

1.1

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

478

1.24

0.85

3.3

2.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

885

0.83

0.84

1.5

—

(3017569) Oxygen content in Arterial blood

1.55

0.81

1.9

2.8

16.95

16.56

0.17

(3015076) Soybean IgE Ab [Units/volume] in Serum

164

1.41

0.80

1.1

0.10

2.77

u/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.67

0.78

1.5

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.59

0.78

1.2

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

165

1.40

0.77

1.1

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

208

1.35

0.77

1.1

1.5

—

(3003129) Base excess in Capillary blood by calculation

174

1.38

0.76

2.2

2.0

0.01

0.55

mmol/l

0.40

168

(3003888) Timothy IgE Ab [Units/volume] in Serum

549

1.21

0.76

1.2

1.1

4.45

4.94

u/ml

0.11

311

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

226

1.33

0.76

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

209

1.34

0.75

1.1

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

175

1.38

0.74

1.1

18.91

2.38

u/ml

0.41

(3005988) Vibrio sp identified in Specimen by Organism specific culture

210

1.34

0.74

1.1

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.84

0.73

1.0

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

379

0.76

0.73

1.6

1.8

—

(3032057) Clostridioides difficile [Presence] in Stool

2.00

0.72

1.8

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.00

0.72

1.0

1.2

1.29

1.78

umol/24h

—

(3019150) Specific gravity of Urine by Refractometry

479

4524

1.08

0.72

3.8

1.02

1.69

kg/l

0.80

354

2988

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

344

3207

1.09

0.72

4.0

4.2

23.02

21.35

1.00

133

1426

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.55

0.72

1.2

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

377

0.77

0.71

3.0

2.4

34.75

107.23

ug/min

2.41

237

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

203

1.33

0.70

1.6

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

1.93

0.70

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

620

1.18

0.69

1.4

1.5

58.45

60.32

ug/l

0.15

620

(3006462) Nitrate [Presence] in Urine

1.56

0.68

2.8

2.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.85

0.68

1.2

3.6

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.85

0.68

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

170

1.36

0.67

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.79

0.66

1.0

1.5

—

(3028433) Virus identified in Specimen by Culture

1.62

0.65

1.0

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

438

4144

1.07

0.64

1.6

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.52

0.62

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.46

0.61

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

182

1.32

0.61

1.6

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.48

0.60

2.2

3.5

38.29

118.08

umol/l

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.5

—

7.90

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.60

0.0

1.3

—

5.60

—

(3022689) Creatine [Moles/volume] in Urine

1.54

0.59

2.4

1.6

4.81

9.71

mmol/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.54

0.59

1.0

43.38

37.66

iu/ml

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

716

1.15

0.58

2.0

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.58

0.0

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.48

0.57

3.5

2.3

15.00

15.71

umol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

320

1.22

0.56

1.3

—

(3024263) Appearance of Synovial fluid

1.47

0.54

2.2

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

267

1.24

0.54

1.4

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

387

3672

1.07

0.53

1.8

1.7

425.36

35139843.55

pmol/l

3.70

330

3156

(3014271) Vancomycin [Susceptibility]

1.41

0.51

2.2

2.6

—

(3016879) Cocaine [Presence] in Urine

113

1019

1.11

0.51

2.8

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.39

0.50

1.3

1.5

11.11

8.70

ug/l

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.49

0.49

3.2

2.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.43

0.49

1.8

1.5

93.44

85.48

nmol/24h

0.18

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.43

0.49

1.1

1.3

—

(44806420) Estimation of glomerular filtration rate

257

0.78

0.49

2.5

2.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

347

1.19

0.45

7.4

3.5

17.38

22.15

mg/l

0.91

233

(3000764) Benzodiazepines [Presence] in Urine

120

1095

1.10

0.45

2.8

2.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

422

1.16

0.45

1.5

1.4

16.55

22.61

u/l

0.93

354

(3020650) Glucose [Presence] in Urine

1.45

0.44

1.1

1.7

0.00

0.04

estimate

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

527

1.14

0.43

1.2

1.1

0.98

1.19

u/ml

0.15

239

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

1.1

0.02

u/ml

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.38

0.41

1.5

2.7

0.50

1.09

—

(3027008) Opiates [Presence] in Urine

120

1102

1.09

0.41

2.8

2.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

41.78

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

123

1.30

0.40

1.4

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

663

1.12

0.40

2.1

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.43

0.39

2.2

3.2

4.60

5.91

ug/l

—

(3028300) Cannabinoids [Presence] in Urine

120

1106

1.09

0.39

2.8

2.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

115

1.31

0.39

1.1

1.2

9.27

8.66

mm/h

0.11

115

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

142

1.27

0.38

10.3

15.0

729.61

832.56

nmol/l

0.41

137

(3027944) Amphetamines [Presence] in Urine

119

1097

1.09

0.38

2.8

1.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.35

0.37

1.0

7.58

6.87

u/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.35

0.37

1.4

33.40

32.54

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

879

1.10

0.36

1.5

1.7

4.56

4.62

mg/l

0.02

635

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.27

0.36

2.1

2.2

—

158.06

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.43

0.35

2.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.43

0.35

2.0

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.43

0.35

2.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.37

0.34

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.37

0.34

1.6

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.37

0.34

1.6

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.33

0.33

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

173

1.22

0.33

1.1

0.23

1.26

u/ml

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

322

1.15

0.32

2.6

3.9

24.18

26.25

u/ml

0.08

315

(3010726) Horse dander IgE Ab [Units/volume] in Serum

522

1.11

0.31

1.1

0.93

1.73

u/ml

0.84

262

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

102

1.28

0.30

2.8

1.8

105.15

102.13

ng/l

0.03

102

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

112

1.25

0.28

2.5

1.6

—

688903.22

iu/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

140

0.78

0.28

1.2

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

160

1.19

0.25

1.8

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

160

1.19

0.25

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

160

1.19

0.25

1.8

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.19

0.21

1.6

2.4

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.11

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

54.86

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

1.16

0.21

1.8

1.4

61.10

49.05

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

6.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.07

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

741

1.07

0.20

4.6

5.9

1.59

1.56

0.14

704

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.25

0.20

1.0

1.1

37.99

48.68

u/ml

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.06

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.23

0.20

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.23

0.20

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.18

0.19

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.13

0.18

1.3

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.13

0.18

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

959

0.95

0.18

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

300

1.10

0.17

1.4

6.68

7.12

mmol/l

0.47

270

(40768800) Prostate Pathology biopsy report

233

1.12

0.17

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.22

0.17

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

129

1.16

0.17

1.7

1.3

67.00

74.50

umol/l

0.89

129

(3019225) pH of Specimen

152

1577

0.96

0.16

5.4

3.9

7.38

7.35

2.98

121

1161

(3041806) Other cells [#/volume] in Blood by Manual count

101

1.19

0.16

1.7

1.5

0.50

0.48

e9/l

0.12

101

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

102

1.18

0.15

1.0

1.4

199.74

156.11

pmol/l

0.58

102

(3045683) HLA typing for celiac disease panel - Blood or Tissue

149

0.87

0.13

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.18

0.12

1.6

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

600

1.05

0.12

2.0

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

456

0.94

0.11

1.1

1.35

3.80

u/ml

2.26

229

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

404

0.94

0.11

1.1

0.05

0.28

u/ml

2.15

130

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

348

1.06

0.10

1.8

1.6

338.51

355.27

mu/l

0.13

287

(1617658) Protocol used for examination of sentinel lymph nodes

164

1.10

0.09

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

124

0.89

0.09

1.1

2.0

—

1.81

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

117

1.11

0.08

8.1

7.5

24.29

165.83

ug/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.84

0.07

1.2

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.12

0.07

2.9

2.5

7.49

8.41

mmol/l

0.58

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

254

2574

0.99

0.07

1.8

1.9

3.30

3.42

ratio

0.86

185

1925

(4146454) Self-monitoring of blood glucose

152

0.92

0.06

4.9

2.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

426

1.03

0.05

1.1

0.79

5.22

u/ml

5.15

189

(40768793) Breast Pathology biopsy report

533

0.98

0.04

1.5

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

360

1.03

0.03

3.4

4.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

133

1336

1.00

0.00

1.6

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

195

1945

1.00

0.00

1.5

1.6

3.21

3.45

mmol/l

2.37

131

1320

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

192

0.99

0.00

2.6

2.2

38.71

24.35

mg/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

127

1.02

0.00

1.0

1.1

1707.77

1422.89

miu/ml

0.54

127

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

100

1.00

-0.00

1.6

1.8

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.02

-0.00

1.0

1.3

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

-0.00

0.0

2.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.02

-0.00

1.0

1.3

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

100

1.00

-0.00

7.1

7.0

—

59.38

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(4133840) Spirometry

0.98

-0.00

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

37.05

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1479.17

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

322.00

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint D3_COAGDEFNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
D3_COAGDEFNAS	1.772 [1.5, 2.09]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.663

During the follow-up period (1.1.1998 — 31.12.2019), 528 out of 6334 females with D3_COAGDEFNAS died.

Males

Parameter	HR [95% CI]	p-value
D3_COAGDEFNAS	1.758 [1.5, 2.06]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 579 out of 3194 males with D3_COAGDEFNAS died.

Mortality risk

Mortality risk for people of age

years, who have D3_COAGDEFNAS.

N-year risk	Females	Males
1	0.219%	0.381%
5	1.244%	2.273%
10	2.897%	5.384%
15	5.705%	10.407%
20	9.837%	17.933%

Relationships between endpoints

↥

Index endpoint: D3_COAGDEFNAS – Other and unspecified coagulation defects

GWS hits: 24

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified coagulation defects

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints